This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Lifestyle-related condition
VWXY20_LIFESTYLE__CONDI
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519870 |
1. Apply sex-specific ruleNone |
519870 |
2. Check conditionsNone |
519870 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
451 |
4. Check minimum number of eventsNone |
451 |
5. Include endpointsNone |
451 |
6. Filter based on genotype QC (FinnGen only) |
433 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- Y9[7-8]
Similar endpoints
↥List of similar endpoints to
Lifestyle-related condition
based on the number of shared cases.
Similar with more cases:
- Other factor of the environment
- Supplementary factors related to causes of morbidity and mortality classified elsewhere
- External causes of morbidity and mortality
- Any prescribed medicine buy
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 433 | 237 | 196 |
| Unadjusted period prevalence (%) | 0.09 | 0.08 | 0.09 |
| Median age at first event (years) | 57.99 | 52.85 | 64.21 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 451
- Matched controls
- 4510
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Y98
ICD-10 Finland
Lifestyle-related condition
+∞
307.7
451
*
T78.4
ICD-10 Finland
Allergy, unspecified
8.8
48.0
65
85
T78.3
ICD-10 Finland
Angioneurotic oedema
18.9
43.3
35
20
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
9.1
42.3
55
68
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
8.3
35.5
49
65
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
6.3
30.7
55
97
T36
ICD-10 Finland
Poisoning by systemic antibiotics
6.1
28.2
52
94
X59
ICD-10 Finland
Exposure to unspecified factor
3.2
26.0
137
544
A46
ICD-10 Finland
Erysipelas
3.4
23.8
104
367
ZZA00
NOMESCO Finland
Split skin graft
7.5
22.3
33
47
S97
ICPC
Chronic ulcer skin
4.3
21.7
60
154
J01FF01
ATC
clindamycin; systemic
2.7
20.9
168
823
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.5
20.8
83
275
SPAT1148
SPAT
Treatment of chronic ulcer or burn
3.3
20.6
90
316
Y57
ICD-10 Finland
Adverse effects in the therapeutic use of other and unspecified drugs and medicaments
8.6
19.8
26
32
NHQ40
NOMESCO Finland
Amputation of toe
15.6
19.7
32
22
TQW11
NOMESCO Finland
Vacuum treatment of wound
7.9
19.3
27
36
WZC00
NOMESCO Finland
Treatment plan or consultation
2.5
19.2
210
1180
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
3.7
19.0
67
204
N02AA05
ATC
oxycodone; systemic
2.8
17.6
112
483
E11.5
ICD-10 Finland
Type 2 diabetes mellitus, with peripheral circulatory complications
7.4
17.6
26
37
S18
ICPC
Laceration/cut
2.3
17.2
251
1578
N03AX09
ATC
lamotrigine; oral
4.4
16.7
44
108
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
4.1
16.7
48
126
SPAT1229
SPAT
Assessment of need for aid
4.0
16.5
49
132
Y96.9
ICD-10 Finland
Unspecified type of accident
6.5
16.1
27
44
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.8
16.1
53
154
NHQ30
NOMESCO Finland
Amputation of foot, transmetatarsal
34.8
15.9
20
6
M86.9
ICD-10 Finland
Osteomyelitis, unspecified
27.4
15.7
21
8
SPAT1301
SPAT
No procedures
2.3
15.5
171
945
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
3.1
15.3
71
256
T84.62
ICD-10 Finland
Osteitis associated with dental implants
29.8
15.3
20
7
A10AB05
ATC
insulin aspart; parenteral
3.4
15.3
59
190
A01
ICPC
Pain general/multiple sites
3.1
15.3
72
262
L28
ICPC
Limited function/disability (L)
2.6
15.2
109
496
TNX50
NOMESCO Finland
Removal of cutom molded cast and internal stretch
4.5
15.1
38
90
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
2.2
15.1
223
1385
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
3.0
15.0
74
276
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
7.1
15.0
23
34
SPAT1149
SPAT
Suture or treatment of traumatic wound
2.9
14.9
78
301
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.3
14.8
145
760
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.7
14.7
96
416
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
4.0
14.7
44
119
A28
ICPC
Limited function/disability NOS
2.6
14.6
100
444
S91.3
ICD-10 Finland
Open wound of other parts of foot
5.3
14.5
30
60
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.6
14.2
93
403
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
2.2
14.2
168
949
SPAT1222
SPAT
Counselling/guidance promoting independent living
2.7
14.2
89
378
A41.9
ICD-10 Finland
Sepsis, unspecified
5.0
14.0
31
66
N02AX02
ATC
tramadol; systemic, rectal
2.1
13.9
223
1416
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
5.6
13.9
27
51
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
6.8
13.8
22
34
SPAT1262
SPAT
Handing over of treatment supplies
2.6
13.6
96
431
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
3.3
13.6
56
188
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.4
13.5
111
535
N17.9
ICD-10 Finland
Acute renal failure, unspecified
5.0
13.3
29
61
A06AD11
ATC
lactulose; oral
2.7
13.2
81
339
SPAT1254
SPAT
Administration of medicine
2.6
13.1
90
399
RD211, ,
NOMESCO Finland
4.1
13.1
37
96
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
3.3
13.1
53
176
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.6
13.0
85
368
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
2.2
12.9
163
938
SAA03
NOMESCO Finland
Extended examination of mouth
2.1
12.8
211
1341
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
4.1
12.6
36
94
R56.8
ICD-10 Finland
Other and unspecified convulsions
3.9
12.6
39
108
A10AE05
ATC
insulin detemir; parenteral
3.7
12.6
41
118
N05AH04
ATC
quetiapine; oral
2.3
12.5
117
596
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
3.1
12.4
56
198
S03.0
ICD-10 Finland
Dislocation of jaw
14.9
12.4
20
14
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
6.2
12.2
21
35
JN3AD
NOMESCO Finland
Abdominal CT examination
2.5
12.2
84
372
A10AE04
ATC
insulin glargine; parenteral
2.8
12.2
68
271
P19
ICPC
Drug abuse
18.7
12.1
18
10
J01MA12
ATC
levofloxacin; systemic
2.4
12.1
98
468
N03AX12
ATC
[U] gabapentin; oral
2.4
11.9
95
450
SPAT1216
SPAT
Assessment of functional ability
2.5
11.9
85
383
ZXD05
NOMESCO Finland
Urgent procedure
2.1
11.9
154
891
C03CA01
ATC
furosemide; systemic
2.1
11.8
140
782
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.4
11.8
95
452
SPAT1263
SPAT
Sampling
2.0
11.7
210
1365
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
2.6
11.6
77
335
TPH04
NOMESCO Finland
Cathetrisation of vein
2.2
11.5
117
615
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
3.2
11.4
48
163
N05AA02
ATC
levomepromazine; systemic
4.1
11.3
32
83
Z50.1
ICD-10 Finland
Other physical therapy
3.7
11.2
37
107
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
3.1
11.1
48
165
Z01.8
ICD-10 Finland
Other specified special examinations
2.2
11.1
117
623
P76
ICPC
Depressive disorder
3.0
11.0
51
183
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.2
11.0
107
551
T84.60
ICD-10 Finland
Gingivitis associated with dental implants
16.0
10.9
17
11
215
Kela drug reimbursment
Diabetes, non-insulin-treated
2.1
10.6
125
693
C01CA24
ATC
epinephrine; parenteral
3.1
10.5
47
165
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
5.6
10.5
20
37
R50.9
ICD-10 Finland
Fever, unspecified
2.3
10.5
89
432
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
5.3
10.4
21
41
A29
ICPC
General symptom/complaint other
2.4
10.4
83
392
Z72.8
ICD-10 Finland
Other problems related to lifestyle
33.4
10.4
13
*
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
3.2
10.3
43
145
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
2.5
10.3
68
294
PD4BC
NOMESCO Finland
Extensive arterigography of lower extremity with X-ray
13.5
10.2
17
13
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.4
10.2
74
335
SPAT1252
SPAT
Overall medication plan or its review
3.1
10.1
44
152
N05AH03
ATC
olanzapine; systemic
3.0
10.1
47
169
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
2.1
10.1
122
682
EBA05
NOMESCO Finland
Complicated extraction of tooth
2.1
10.0
123
690
X44
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances
7.9
10.0
22
29
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.1
9.9
109
586
Z00.0
ICD-10 Finland
General medical examination
2.1
9.9
111
601
A11CC03
ATC
alfacalcidol; systemic
5.3
9.9
20
39
P01AB01
ATC
metronidazole; oral, rectal
1.9
9.8
197
1308
N03AX16
ATC
[U] pregabalin
2.1
9.8
119
664
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
3.4
9.8
36
112
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
3.0
9.8
44
155
QDG20
NOMESCO Finland
Operation for chronic ulcer or fistula of skin of lower limb
13.8
9.7
16
12
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
5.2
9.7
20
40
WX872
NOMESCO Finland
Intensive care
3.5
9.6
34
103
WZC10
NOMESCO Finland
Written specialist consultation based on a referral from a dentist or a physician
3.6
9.6
33
98
H02AB06
ATC
prednisolone; systemic
1.9
9.6
228
1595
103
Kela drug reimbursment
Diabetes, insulin-treated
2.0
9.6
130
756
EB1AA
NOMESCO Finland
Intraoral radiographic dental examination
1.9
9.5
265
1947
SPAT1310
SPAT
Counselling related to known health issue
1.9
9.4
160
1003
N05AX08
ATC
risperidone; systemic
2.7
9.4
54
218
N05AX12
ATC
aripiprazole; systemic
3.7
9.2
30
86
N05AD01
ATC
haloperidol; systemic
4.4
9.2
23
54
P29
ICPC
Psychological sympt/compl other
2.6
9.2
55
226
N05CF01
ATC
zopiclone; oral
1.9
9.2
154
960
Y96.8
ICD-10 Finland
Other type of accident
11.8
9.1
16
14
L89
ICD-10 Finland
Decubitus ulcer and pressure area
7.3
9.1
21
30
J01MA02
ATC
ciprofloxacin; systemic
1.9
9.1
180
1183
K02.2
ICD-10 Finland
Caries of cementum
3.6
9.1
30
87
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
1.9
9.1
154
964
E10.5
ICD-10 Finland
Type 1 diabetes mellitus, With peripheral circulatory complications
37.5
9.1
11
*
AA1AD
NOMESCO Finland
CT of head and brain
1.9
8.9
138
838
WZC30
NOMESCO Finland
Teaching
2.2
8.8
88
454
EBA15
NOMESCO Finland
Extraction of multiple teeth
4.0
8.8
25
65
WX110
NOMESCO Finland
Infiltration anesthesia
2.0
8.8
341
2753
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
2.0
8.7
114
653
SAA01
NOMESCO Finland
Simple examination of mouth
2.0
8.6
342
2771
P99
ICPC
Psychological disorders other
4.0
8.6
25
66
T83.0
ICD-10 Finland
Mechanical complication of urinary (indwelling) catheter
28.1
8.5
11
*
SPAT1234
SPAT
Support of social functional capacity
3.5
8.5
30
91
Z3231
NOMESCO Finland
Registered nurse
1.9
8.5
136
832
SPAT1260
SPAT
Consultation of another employee
2.1
8.5
95
513
EBA00
NOMESCO Finland
Extraction of tooth
1.8
8.4
184
1240
Y89.9
ICD-10 Finland
Sequelae of unspecified external cause
8.8
8.4
17
20
N02BE01
ATC
paracetamol; systemic, rectal
2.7
8.3
413
3614
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
2.4
8.3
59
264
F60.31
ICD-10 Finland
Emotionally unstable personality disorder, borderline condition
7.8
8.2
18
24
T74.1
ICD-10 Finland
Physical abuse
4.5
8.2
20
46
Y88
ICD-10 Finland
Sequelae with surgical and medical care as external cause
17.6
8.1
12
7
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.4
8.1
60
273
S09
ICPC
Infected finger/toe
4.0
8.1
23
60
ZX120
NOMESCO Finland
Intravenous
2.5
8.0
54
235
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.9
8.0
134
829
T90
ICPC
Diabetes non-insulin dependent
1.9
8.0
113
662
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
2.8
7.9
42
162
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
3.9
7.9
23
61
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
2.5
7.9
53
231
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.1
7.8
79
409
N03AG01
ATC
valproic acid; systemic, rectal
2.8
7.8
39
146
UKC02
NOMESCO Finland
Cystoscopy
2.2
7.8
76
388
N06AX11
ATC
mirtazapine; oral
1.8
7.7
166
1107
T87.4
ICD-10 Finland
Infection of amputation stump
45.8
7.7
9
*
SPAT1307
SPAT
Psychosocial counselling and guidance
2.8
7.6
39
148
R51.80
ICD-10 Finland
Headache
2.0
7.6
95
532
L04AD02
ATC
tacrolimus; systemic
10.3
7.6
14
14
N02AJ06
ATC
codeine and paracetamol; systemic
1.7
7.5
211
1516
TPX10
NOMESCO Finland
Implantation of vascular injection port
4.0
7.5
21
54
XQ800
NOMESCO Finland
Prick test
2.7
7.5
40
155
J45.9
ICD-10 Finland
Asthma, unspecified
2.0
7.5
96
542
N30.0
ICD-10 Finland
Acute cystitis
2.1
7.5
84
452
QCB10
NOMESCO Finland
Major dressing of wound of skin of upper limb
4.5
7.5
18
41
R11
ICD-10 Finland
Nausea and vomiting
2.4
7.5
52
230
TK800
NOMESCO Finland
Hemodialysis
6.2
7.5
19
32
M79.6
ICD-10 Finland
Pain in limb
1.7
7.4
212
1530
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.9
7.4
112
669
EBB10
NOMESCO Finland
Insertion of dental implant
8.6
7.4
15
18
ECB00
NOMESCO Finland
Suture of gingiva
3.5
7.4
25
74
NGQ20
NOMESCO Finland
Amputation of lower leg
11.1
7.3
13
12
F29
ICD-10 Finland
Unspecified nonorganic psychosis
3.2
7.3
29
95
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.2
7.3
70
355
N03AX14
ATC
levetiracetam; systemic
4.4
7.3
18
42
K90
ICPC
Stroke/cerebrovascular accident
4.4
7.3
18
42
F20.9
ICD-10 Finland
Schizophrenia, unspecified
4.4
7.3
18
42
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.7
7.3
174
1193
K59.09
ICD-10 Finland
Constipation, unspecified
2.6
7.2
41
164
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.8
7.2
133
844
A02BC02
ATC
pantoprazole; systemic
1.8
7.2
307
2468
X84
ICD-10 Finland
Intentional self-harm by unspecified means
20.4
7.2
10
5
T88.7
ICD-10 Finland
Unspecified adverse effect of drug or medicament
6.2
7.1
18
30
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.2
7.1
66
330
SPAT1255
SPAT
Intravenous administration of medicine
2.8
7.1
35
130
V03AE01
ATC
polystyrene sulfonate; oral
10.3
7.1
13
13
SPAT1167
SPAT
Insertion of urinary catheter
4.3
7.1
18
43
D64.9
ICD-10 Finland
Anaemia, unspecified
2.3
7.0
53
243
C07AB07
ATC
bisoprolol; oral
1.7
7.0
210
1528
SPAT1360
SPAT
Extensive global examination
2.8
7.0
35
131
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
5.6
7.0
19
35
B03XA02
ATC
darbepoetin alfa; parenteral
6.0
7.0
18
31
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
3.5
6.9
24
72
F11.22
ICD-10 Finland
Addiction-induced dependence is currently independent but uses substitute intermittent medication
14.1
6.9
11
8
F10.30
ICD-10 Finland
Withdrawal symptoms caused by alcohol uncomplicated
8.5
6.9
14
17
SPAT1097
SPAT
Recording of ECG
2.1
6.9
67
342
S06.0
ICD-10 Finland
Concussion
2.1
6.8
65
328
P72
ICPC
Schizophrenia
4.4
6.8
17
40
C07AA05
ATC
propranolol; systemic
1.9
6.8
102
607
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.7
6.7
210
1539
TQW40
NOMESCO Finland
Remowal of suture of skin
2.6
6.7
38
152
QD9S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in lower extremities, unspecified
22.9
6.7
9
*
WX212
NOMESCO Finland
Femoral plexus blockade
4.1
6.7
18
45
L03.9
ICD-10 Finland
Cellulitis, unspecified
6.0
6.7
17
29
N05BA04
ATC
oxazepam; oral
1.8
6.7
129
829
P15
ICPC
Chronic alcohol abuse
3.6
6.6
22
64
S81.8
ICD-10 Finland
Open wound of other parts of lower leg
3.6
6.6
22
64
S76
ICPC
Skin infection other
2.8
6.6
34
129
Z71.8
ICD-10 Finland
Other specified counselling
1.7
6.6
169
1174
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
2.8
6.6
33
124
127
Kela drug reimbursment
Transplant complication
7.0
6.6
15
22
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
2.9
6.5
31
113
F31.4
ICD-10 Finland
Bipolar affective disorder, current episode severe depression without psychotic symptoms
7.6
6.5
14
19
K05.31
ICD-10 Finland
Periodontitis pronounced
2.3
6.5
53
252
PBL09
NOMESCO Finland
Construction of arteriovenous fistula from brachial artery
70.8
6.4
7
*
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.8
6.4
116
729
R1250
NOMESCO Finland
Evaluation of functional capability
3.8
6.4
19
51
SPAT1153
SPAT
Removal of sutures
1.7
6.4
137
905
SPAT1249
SPAT
Treatment-related counselling outside office
1.7
6.4
174
1227
E000001, ,
ATC
1.9
6.4
92
539
Z49.1
ICD-10 Finland
Extracorporeal dialysis
8.3
6.4
13
16
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
2.7
6.4
34
132
D10
ICPC
Vomiting
2.6
6.4
36
144
F17.29
ICD-10 Finland
Addiction caused by tobacco UNS
5.7
6.4
17
31
WX892
NOMESCO Finland
Monitored bed care
2.5
6.3
39
163
J01DB01
ATC
cefalexin; oral
1.9
6.3
376
3259
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.8
6.3
103
628
Z72.2
ICD-10 Finland
Drug use
18.3
6.3
9
5
F11.25
ICD-10 Finland
Relationship caused by opiates continuously used
18.3
6.3
9
5
N07BB01
ATC
disulfiram; oral
2.9
6.3
29
104
IFC01, ,
SPAT
+∞
6.3
6
*
T91.3
ICD-10 Finland
Sequelae of injury of spinal cord
+∞
6.3
6
*
F10.25
ICD-10 Finland
Alcohol dependence continuous use
5.5
6.2
17
32
N18.8
ICD-10 Finland
Other chronic renal failure
5.5
6.2
17
32
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
2.2
6.2
54
263
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
3.9
6.1
18
48
R06AE07
ATC
cetirizine; oral
1.6
6.1
197
1445
H43.1
ICD-10 Finland
Vitreous haemorrhage
4.2
6.1
16
39
Z94.0
ICD-10 Finland
Kidney transplant status
8.8
6.1
12
14
P03
ICPC
Feeling depressed
2.1
6.1
59
300
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
2.2
6.1
50
238
M05BX04
ATC
denosumab; parenteral
2.8
6.0
30
112
R05
ICPC
Cough
1.7
6.0
122
791
E0000UV, ,
ATC
1.6
6.0
192
1404
285
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
2.7
6.0
33
130
TimeCodeWAS
↥TODO / Current known limitations:
- Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
- Legend / how to read the glyphs.
- Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
- Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
- Download CSV.
- No filters and sorters.
- Limited amount of endpoints (~400) having TimeCodeWAS data.
- Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
Ulcer of lower limb, not elsewhere classified
L97 [45591659]
L97 [45591659]
2.1e+00
2.2e+00
2.5e+00
—
2.7e+00
2.8e+00
2.4e+00
cases:3.33%
controls:0.42%
cases:2.88%
controls:0.33%
cases:1.33%
controls:0.11%
—
—
cases:1.55%
controls:0.11%
cases:4.41%
controls:0.27%
cases:6.94%
controls:0.66%
15
19
436
4491
13
15
438
4495
6
5
445
4505
—
7
5
444
4503
19
12
412
4394
25
25
335
3758
Emotionally unstable personality disorder, impulsive
F60.30 [2000502022]
F60.30 [2000502022]
2.3e+00
2.5e+00
2.5e+00
—
2.7e+00
1.9e+00
2.3e+00
cases:2.66%
controls:0.27%
cases:2.22%
controls:0.18%
cases:1.33%
controls:0.11%
—
—
cases:1.55%
controls:0.11%
cases:1.62%
controls:0.25%
cases:4.44%
controls:0.45%
12
12
439
4498
10
8
441
4502
6
5
445
4505
—
7
5
444
4503
7
11
424
4395
16
17
344
3766
fentanyl; nasal, sublingual, transdermal
N02AB03 [21604272]
N02AB03 [21604272]
2.7e+00
2.2e+00
2.5e+00
—
2.2e+00
2.1e+00
—
cases:2.00%
controls:0.13%
cases:1.33%
controls:0.16%
cases:1.33%
controls:0.11%
—
—
cases:1.33%
controls:0.16%
cases:1.86%
controls:0.23%
—
—
9
6
442
4504
6
7
445
4503
6
5
445
4505
—
6
7
445
4501
8
10
423
4396
—
Treatment of chronic ulcer or burn
SPAT1148 [2001700249]
SPAT1148 [2001700249]
1.3e+00
1.6e+00
2.4e+00
—
2.5e+00
2.1e+00
1.5e+00
cases:9.09%
controls:2.57%
cases:5.32%
controls:1.15%
cases:2.88%
controls:0.27%
—
—
cases:3.99%
controls:0.35%
cases:8.12%
controls:1.02%
cases:10.28%
controls:2.38%
41
116
410
4394
24
52
427
4458
13
12
438
4498
—
18
16
433
4492
35
45
396
4361
37
90
323
3693
Atherosclerosis of arteries of extremities
I70.2 [45538421]
I70.2 [45538421]
1.2e+00
1.7e+00
2.2e+00
—
2.6e+00
1.7e+00
1.4e+00
cases:4.88%
controls:1.60%
cases:3.55%
controls:0.67%
cases:2.22%
controls:0.24%
—
—
cases:3.33%
controls:0.24%
cases:5.10%
controls:1.02%
cases:6.11%
controls:1.59%
22
72
429
4438
16
30
435
4480
10
11
441
4499
—
15
11
436
4497
22
45
409
4361
22
60
338
3723
oxycodone; oral, parenteral
N02AA05 [21604260]
N02AA05 [21604260]
1.5e+00
1.5e+00
2.3e+00
—
2.2e+00
1.8e+00
1.4e+00
cases:7.54%
controls:1.77%
cases:5.54%
controls:1.31%
cases:3.33%
controls:0.35%
—
—
cases:3.10%
controls:0.35%
cases:7.42%
controls:1.29%
cases:12.22%
controls:3.44%
34
80
417
4430
25
59
426
4451
15
16
436
4494
—
14
16
437
4492
32
57
399
4349
44
130
316
3653
Chronic ulcer skin
S97 [2002001061]
S97 [2002001061]
1.5e+00
2.0e+00
2.8e+00
—
—
2.6e+00
1.6e+00
cases:3.10%
controls:0.71%
cases:3.55%
controls:0.49%
cases:2.22%
controls:0.13%
—
—
—
—
cases:3.25%
controls:0.25%
cases:6.11%
controls:1.24%
14
32
437
4478
16
22
435
4488
10
6
441
4504
—
—
14
11
417
4395
22
47
338
3736
Emotionally unstable personality disorder, borderline condition
F60.31 [2000502023]
F60.31 [2000502023]
2.1e+00
2.5e+00
—
—
—
2.6e+00
2.9e+00
cases:2.22%
controls:0.29%
cases:1.55%
controls:0.13%
—
—
—
—
—
—
cases:1.86%
controls:0.14%
cases:3.61%
controls:0.21%
10
13
441
4497
7
6
444
4504
—
—
—
8
6
423
4400
13
8
347
3775
Bacteria identified in Skin by Aerobe culture
620-5 [3007853]
620-5 [3007853]
1.0e+00
1.1e+00
2.6e+00
1.0e+50
2.8e+00
1.4e+00
9.6e-01
cases:7.98%
controls:3.04%
cases:3.55%
controls:1.26%
cases:2.00%
controls:0.16%
cases:1.11%
controls:0.00%
cases:1.77%
controls:0.11%
cases:5.34%
controls:1.32%
cases:10.56%
controls:4.31%
36
137
415
4373
16
57
435
4453
9
7
442
4503
5
0
446
4510
8
5
443
4503
23
58
408
4348
38
163
322
3620
Dentistry
C5 [903277]
C5 [903277]
1.3e+00
1.4e+00
2.1e+00
1.0e+50
3.5e+00
2.3e+00
1.2e+00
cases:7.32%
controls:2.13%
cases:3.77%
controls:0.98%
cases:1.11%
controls:0.13%
cases:16.19%
controls:0.00%
cases:4.43%
controls:0.13%
cases:8.35%
controls:0.86%
cases:8.89%
controls:2.75%
33
96
418
4414
17
44
434
4466
5
6
446
4504
73
0
378
4510
20
6
431
4502
36
38
395
4368
32
104
328
3679
Type 2 diabetes mellitus, with multiple complications
E11.7 [45561950]
E11.7 [45561950]
1.7e+00
1.6e+00
2.9e+00
—
—
1.9e+00
1.6e+00
cases:4.43%
controls:0.82%
cases:2.88%
controls:0.58%
cases:2.00%
controls:0.11%
—
—
—
—
cases:2.55%
controls:0.41%
cases:5.56%
controls:1.22%
20
37
431
4473
13
26
438
4484
9
5
442
4505
—
—
11
18
420
4388
20
46
340
3737
Office Visit
OMOP4822458 [581477]
OMOP4822458 [581477]
1.4e+00
1.1e+00
1.7e+00
1.0e+50
2.7e+00
1.6e+00
1.2e+00
cases:29.93%
controls:9.93%
cases:9.76%
controls:3.33%
cases:2.44%
controls:0.47%
cases:1.33%
controls:0.00%
cases:5.99%
controls:0.42%
cases:9.98%
controls:2.25%
cases:13.61%
controls:4.55%
135
448
316
4062
44
150
407
4360
11
21
440
4489
6
0
445
4510
27
19
424
4489
43
99
388
4307
49
172
311
3611
Vascular Surgery
77 [38004496]
77 [38004496]
8.4e-01
1.2e+00
2.2e+00
—
1.9e+00
1.7e+00
1.5e+00
cases:8.43%
controls:3.81%
cases:4.21%
controls:1.31%
cases:2.66%
controls:0.31%
—
—
cases:2.44%
controls:0.38%
cases:7.66%
controls:1.43%
cases:12.78%
controls:3.22%
38
172
413
4338
19
59
432
4451
12
14
439
4496
—
11
17
440
4491
33
63
398
4343
46
122
314
3661
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]
1988-5 [3020460]
3.3e-01
6.7e-01
1.2e+00
4.0e+00
1.5e+00
7.2e-01
5.3e-01
cases:50.11%
controls:41.86%
cases:43.90%
controls:28.56%
cases:18.18%
controls:6.01%
cases:16.85%
controls:0.35%
cases:21.51%
controls:5.97%
cases:45.48%
controls:28.96%
cases:73.33%
controls:61.70%
226
1888
225
2622
198
1288
253
3222
82
271
369
4239
76
16
375
4494
97
269
354
4239
196
1276
235
3130
264
2334
96
1449
Base excess in Venous blood by calculation
1927-3 [3002032]
1927-3 [3002032]
1.4e+00
1.5e+00
1.8e+00
—
1.9e+00
1.1e+00
9.8e-01
cases:6.43%
controls:1.71%
cases:6.43%
controls:1.44%
cases:1.77%
controls:0.29%
—
—
cases:1.77%
controls:0.27%
cases:4.18%
controls:1.36%
cases:11.67%
controls:4.71%
29
77
422
4433
29
65
422
4445
8
13
443
4497
—
8
12
443
4496
18
60
413
4346
42
178
318
3605
General Practice
1 [38004446]
1 [38004446]
9.3e-01
1.3e+00
2.0e+00
—
2.3e+00
1.2e+00
1.0e+00
cases:33.70%
controls:16.67%
cases:20.62%
controls:6.78%
cases:7.32%
controls:1.06%
—
—
cases:9.53%
controls:1.02%
cases:18.79%
controls:6.38%
cases:36.94%
controls:17.42%
152
752
299
3758
93
306
358
4204
33
48
418
4462
—
43
46
408
4462
81
281
350
4125
133
659
227
3124
clindamycin; oral, parenteral
J01FF01 [21602985]
J01FF01 [21602985]
1.4e+00
1.3e+00
—
—
2.7e+00
1.9e+00
1.4e+00
cases:12.20%
controls:3.41%
cases:3.99%
controls:1.11%
—
—
—
—
cases:2.00%
controls:0.13%
cases:5.10%
controls:0.82%
cases:11.67%
controls:3.15%
55
154
396
4356
18
50
433
4460
—
—
9
6
442
4502
22
36
409
4370
42
119
318
3664
pH of Venous blood
2746-6 [3012544]
2746-6 [3012544]
1.3e+00
1.5e+00
1.8e+00
—
1.9e+00
1.1e+00
9.7e-01
cases:6.21%
controls:1.73%
cases:6.43%
controls:1.44%
cases:1.55%
controls:0.27%
—
—
cases:1.77%
controls:0.27%
cases:4.18%
controls:1.36%
cases:12.22%
controls:5.02%
28
78
423
4432
29
65
422
4445
7
12
444
4498
—
8
12
443
4496
18
60
413
4346
44
190
316
3593
Mental and behavioural disorders due to use of alcohol, Harmful use
F10.1 [45595844]
F10.1 [45595844]
1.5e+00
1.8e+00
2.3e+00
—
—
1.8e+00
1.2e+00
cases:4.43%
controls:1.02%
cases:2.44%
controls:0.40%
cases:1.33%
controls:0.13%
—
—
—
—
cases:2.32%
controls:0.39%
cases:4.17%
controls:1.30%
20
46
431
4464
11
18
440
4492
6
6
445
4504
—
—
10
17
421
4389
15
49
345
3734
Bacteria identified in Blood by Culture
600-7 [3023368]
600-7 [3023368]
8.4e-01
1.3e+00
2.1e+00
1.0e+50
2.2e+00
1.2e+00
9.6e-01
cases:12.86%
controls:5.96%
cases:11.97%
controls:3.53%
cases:3.55%
controls:0.44%
cases:3.99%
controls:0.00%
cases:4.43%
controls:0.53%
cases:10.44%
controls:3.25%
cases:24.44%
controls:11.00%
58
269
393
4241
54
159
397
4351
16
20
435
4490
18
0
433
4510
20
24
431
4484
45
143
386
4263
88
416
272
3367
duloxetine; oral
N06AX21 [21604749]
N06AX21 [21604749]
1.0e+00
1.2e+00
1.7e+00
—
2.4e+00
1.3e+00
9.1e-01
cases:5.10%
controls:1.86%
cases:3.77%
controls:1.20%
cases:1.77%
controls:0.33%
—
—
cases:2.00%
controls:0.18%
cases:3.71%
controls:1.02%
cases:5.28%
controls:2.19%
23
84
428
4426
17
54
434
4456
8
15
443
4495
—
9
8
442
4500
16
45
415
4361
19
83
341
3700
Urea [Moles/volume] in Serum or Plasma
22664-7 [3020779]
22664-7 [3020779]
1.0e+00
1.6e+00
1.6e+00
—
1.9e+00
1.2e+00
1.1e+00
cases:5.99%
controls:2.20%
cases:6.43%
controls:1.33%
cases:2.00%
controls:0.40%
—
—
cases:2.22%
controls:0.33%
cases:5.10%
controls:1.52%
cases:10.56%
controls:3.81%
27
99
424
4411
29
60
422
4450
9
18
442
4492
—
10
15
441
4493
22
67
409
4339
38
144
322
3639
General medical examination
Z00.0 [45585791]
Z00.0 [45585791]
9.5e-01
1.7e+00
3.0e+00
—
—
2.0e+00
8.6e-01
cases:8.87%
controls:3.61%
cases:4.88%
controls:0.95%
cases:2.22%
controls:0.11%
—
—
—
—
cases:6.73%
controls:0.98%
cases:7.50%
controls:3.30%
40
163
411
4347
22
43
429
4467
10
5
441
4505
—
—
29
43
402
4363
27
125
333
3658
INR in Blood by Coagulation assay
34714-6 [3032080]
34714-6 [3032080]
4.3e-01
8.0e-01
1.0e+00
3.3e+00
1.1e+00
8.9e-01
9.4e-01
cases:19.73%
controls:13.75%
cases:17.74%
controls:8.82%
cases:8.20%
controls:3.04%
cases:5.76%
controls:0.22%
cases:8.87%
controls:3.24%
cases:19.03%
controls:8.81%
cases:39.72%
controls:20.41%
89
620
362
3890
80
398
371
4112
37
137
414
4373
26
10
425
4500
40
146
411
4362
82
388
349
4018
143
772
217
3011
Fall on same level from slipping, tripping and stumbling
W01 [45756243]
W01 [45756243]
8.3e-01
1.2e+00
2.2e+00
—
2.7e+00
8.8e-01
6.2e-01
cases:10.42%
controls:4.81%
cases:4.66%
controls:1.49%
cases:2.00%
controls:0.22%
—
—
cases:2.88%
controls:0.20%
cases:4.64%
controls:1.97%
cases:11.67%
controls:6.66%
47
217
404
4293
21
67
430
4443
9
10
442
4500
—
13
9
438
4499
20
87
411
4319
42
252
318
3531
Exposure to unspecified factor
X59 [45756412]
X59 [45756412]
1.2e+00
1.6e+00
2.7e+00
1.0e+50
—
1.9e+00
1.2e+00
cases:8.43%
controls:2.82%
cases:4.66%
controls:1.02%
cases:1.55%
controls:0.11%
cases:2.00%
controls:0.00%
—
—
cases:6.03%
controls:1.00%
cases:9.72%
controls:3.15%
38
127
413
4383
21
46
430
4464
7
5
444
4505
9
0
442
4510
—
26
44
405
4362
35
119
325
3664
Bicarbonate [Moles/volume] in Venous blood
14627-4 [3027273]
14627-4 [3027273]
1.8e+00
2.0e+00
2.3e+00
—
2.0e+00
1.5e+00
1.0e+00
cases:4.43%
controls:0.73%
cases:4.43%
controls:0.64%
cases:1.11%
controls:0.11%
—
—
cases:1.33%
controls:0.18%
cases:3.02%
controls:0.68%
cases:6.94%
controls:2.59%
20
33
431
4477
20
29
431
4481
5
5
446
4505
—
6
8
445
4500
13
30
418
4376
25
98
335
3685
Nephrology
39 [38004479]
39 [38004479]
1.2e+00
1.4e+00
1.4e+00
—
1.9e+00
1.4e+00
1.0e+00
cases:5.32%
controls:1.64%
cases:4.88%
controls:1.29%
cases:2.44%
controls:0.60%
—
—
cases:3.33%
controls:0.53%
cases:5.80%
controls:1.43%
cases:5.00%
controls:1.82%
24
74
427
4436
22
58
429
4452
11
27
440
4483
—
15
24
436
4484
25
63
406
4343
18
69
342
3714
Sodium [Moles/volume] in Serum or Plasma
2951-2 [3019550]
2951-2 [3019550]
3.6e-01
5.6e-01
1.1e+00
3.8e+00
1.3e+00
6.5e-01
4.6e-01
cases:53.88%
controls:45.01%
cases:49.00%
controls:35.43%
cases:19.73%
controls:7.45%
cases:16.19%
controls:0.42%
cases:21.95%
controls:7.10%
cases:53.60%
controls:37.54%
cases:76.67%
controls:67.38%
243
2030
208
2480
221
1598
230
2912
89
336
362
4174
73
19
378
4491
99
320
352
4188
231
1654
200
2752
276
2549
84
1234
epinephrine; parenteral
C01CA24 [21600303]
C01CA24 [21600303]
1.5e+00
2.4e+00
—
—
—
2.4e+00
1.9e+00
cases:4.21%
controls:0.98%
cases:5.10%
controls:0.47%
—
—
—
—
—
—
cases:4.18%
controls:0.41%
cases:7.78%
controls:1.19%
19
44
432
4466
23
21
428
4489
—
—
—
18
18
413
4388
28
45
332
3738
epinephrine
S01EA01 [21603673]
S01EA01 [21603673]
1.5e+00
2.4e+00
—
—
—
2.4e+00
1.9e+00
cases:4.21%
controls:0.98%
cases:5.10%
controls:0.47%
—
—
—
—
—
—
cases:4.18%
controls:0.41%
cases:7.78%
controls:1.19%
19
44
432
4466
23
21
428
4489
—
—
—
18
18
413
4388
28
45
332
3738
Hemoglobin [Mass/volume] in Venous blood
30350-3 [3004119]
30350-3 [3004119]
1.8e+00
1.8e+00
2.2e+00
—
1.8e+00
1.5e+00
1.0e+00
cases:3.99%
controls:0.71%
cases:3.99%
controls:0.71%
cases:1.33%
controls:0.16%
—
—
cases:1.11%
controls:0.18%
cases:3.02%
controls:0.70%
cases:8.89%
controls:3.33%
18
32
433
4478
18
32
433
4478
6
7
445
4503
—
5
8
446
4500
13
31
418
4375
32
126
328
3657
gabapentin; oral
N02BF01 [955005]
N02BF01 [955005]
1.1e+00
1.5e+00
1.6e+00
—
1.5e+00
1.5e+00
1.0e+00
cases:8.20%
controls:2.88%
cases:7.54%
controls:1.84%
cases:2.88%
controls:0.58%
—
—
cases:2.44%
controls:0.58%
cases:8.12%
controls:1.97%
cases:13.89%
controls:5.42%
37
130
414
4380
34
83
417
4427
13
26
438
4484
—
11
26
440
4482
35
87
396
4319
50
205
310
3578
Emergency Room Visit
ER [9203]
ER [9203]
8.1e-01
1.1e+00
2.1e+00
—
1.9e+00
1.2e+00
1.1e+00
cases:61.20%
controls:41.29%
cases:34.37%
controls:14.50%
cases:12.42%
controls:1.77%
—
—
cases:10.64%
controls:1.80%
cases:30.16%
controls:11.39%
cases:50.56%
controls:25.67%
276
1862
175
2648
155
654
296
3856
56
80
395
4430
—
48
81
403
4427
130
502
301
3904
182
971
178
2812
Psychiatry
26 [38004469]
26 [38004469]
1.1e+00
1.2e+00
1.5e+00
—
1.7e+00
1.5e+00
1.1e+00
cases:20.18%
controls:7.52%
cases:11.53%
controls:3.92%
cases:7.10%
controls:1.69%
—
—
cases:8.87%
controls:1.66%
cases:15.08%
controls:3.88%
cases:20.56%
controls:7.67%
91
339
360
4171
52
177
399
4333
32
76
419
4434
—
40
75
411
4433
65
171
366
4235
74
290
286
3493
General Surgery
2 [38004447]
2 [38004447]
9.5e-01
1.2e+00
1.9e+00
—
1.6e+00
1.3e+00
1.1e+00
cases:27.27%
controls:12.66%
cases:10.64%
controls:3.61%
cases:2.66%
controls:0.40%
—
—
cases:3.10%
controls:0.62%
cases:10.44%
controls:3.00%
cases:20.83%
controls:7.80%
123
571
328
3939
48
163
403
4347
12
18
439
4492
—
14
28
437
4480
45
132
386
4274
75
295
285
3488
Inpatient Hospital
21 [8717]
21 [8717]
6.6e-01
1.1e+00
2.0e+00
—
2.1e+00
1.3e+00
1.0e+00
cases:47.67%
controls:31.91%
cases:25.50%
controls:10.44%
cases:9.53%
controls:1.42%
—
—
cases:11.97%
controls:1.64%
cases:22.74%
controls:7.72%
cases:32.50%
controls:15.04%
215
1439
236
3071
115
471
336
4039
43
64
408
4446
—
54
74
397
4434
98
340
333
4066
117
569
243
3214
Potassium [Moles/volume] in Serum or Plasma
2823-3 [3023103]
2823-3 [3023103]
3.3e-01
5.5e-01
1.1e+00
3.7e+00
1.3e+00
6.0e-01
4.5e-01
cases:53.66%
controls:45.39%
cases:49.22%
controls:35.92%
cases:19.96%
controls:7.69%
cases:15.74%
controls:0.44%
cases:21.95%
controls:7.14%
cases:52.90%
controls:38.08%
cases:76.67%
controls:67.64%
242
2047
209
2463
222
1620
229
2890
90
347
361
4163
71
20
380
4490
99
322
352
4186
228
1678
203
2728
276
2559
84
1224
Allergy, unspecified
T78.4 [45580373]
T78.4 [45580373]
1.5e+00
2.4e+00
—
1.0e+50
—
2.2e+00
1.9e+00
cases:2.88%
controls:0.69%
cases:2.44%
controls:0.22%
—
—
cases:8.43%
controls:0.00%
—
—
cases:2.09%
controls:0.23%
cases:3.61%
controls:0.56%
13
31
438
4479
11
10
440
4500
—
38
0
413
4510
—
9
10
422
4396
13
21
347
3762
darbepoetin alfa; parenteral
B03XA02 [21601134]
B03XA02 [21601134]
2.0e+00
2.4e+00
—
—
—
1.9e+00
1.7e+00
cases:1.77%
controls:0.24%
cases:2.00%
controls:0.18%
—
—
—
—
—
—
cases:1.62%
controls:0.25%
cases:2.50%
controls:0.48%
8
11
443
4499
9
8
442
4502
—
—
—
7
11
424
4395
9
18
351
3765
Laceration/cut
S18 [2002000983]
S18 [2002000983]
8.7e-01
9.8e-01
1.7e+00
—
2.1e+00
1.4e+00
9.2e-01
cases:22.62%
controls:10.93%
cases:10.42%
controls:4.19%
cases:3.10%
controls:0.55%
—
—
cases:5.76%
controls:0.78%
cases:14.39%
controls:3.97%
cases:29.17%
controls:14.12%
102
493
349
4017
47
189
404
4321
14
25
437
4485
—
26
35
425
4473
62
175
369
4231
105
534
255
3249
Type 2 diabetes mellitus, with peripheral circulatory complications
E11.5 [45557114]
E11.5 [45557114]
2.6e+00
—
—
—
—
2.7e+00
2.6e+00
cases:2.44%
controls:0.18%
—
—
—
—
—
—
—
—
cases:1.62%
controls:0.11%
cases:3.06%
controls:0.24%
11
8
440
4502
—
—
—
—
7
5
424
4401
11
9
349
3774
Outpatient Visit
OP [9202]
OP [9202]
9.2e-01
6.6e-01
5.8e-01
3.7e+00
1.3e+00
7.6e-01
2.7e-01
cases:90.69%
controls:79.53%
cases:72.51%
controls:57.74%
cases:21.95%
controls:13.66%
cases:20.84%
controls:0.64%
cases:33.04%
controls:12.36%
cases:75.41%
controls:58.97%
cases:91.67%
controls:89.35%
409
3587
42
923
327
2604
124
1906
99
616
352
3894
94
29
357
4481
149
557
302
3951
325
2598
106
1808
330
3380
30
403
CBC panel - Blood by Automated count
58410-2 [40761511]
58410-2 [40761511]
2.5e-01
5.3e-01
1.4e+00
4.0e+00
1.3e+00
5.8e-01
3.3e-01
cases:52.99%
controls:46.78%
cases:44.79%
controls:32.33%
cases:20.18%
controls:6.10%
cases:15.30%
controls:0.33%
cases:20.84%
controls:6.46%
cases:46.64%
controls:32.84%
cases:71.94%
controls:64.76%
239
2110
212
2400
202
1458
249
3052
91
275
360
4235
69
15
382
4495
94
291
357
4217
201
1447
230
2959
259
2450
101
1333
paracetamol; oral, parenteral, rectal
N02BE01 [21604344]
N02BE01 [21604344]
6.7e-01
7.0e-01
9.7e-01
2.6e+00
1.3e+00
7.9e-01
7.6e-01
cases:59.65%
controls:43.10%
cases:39.02%
controls:24.15%
cases:10.42%
controls:4.21%
cases:1.77%
controls:0.13%
cases:13.53%
controls:4.21%
cases:40.60%
controls:23.74%
cases:68.89%
controls:50.86%
269
1944
182
2566
176
1089
275
3421
47
190
404
4320
8
6
443
4504
61
190
390
4318
175
1046
256
3360
248
1924
112
1859
Phosphate [Moles/volume] in Serum or Plasma
14879-1 [3003458]
14879-1 [3003458]
1.1e+00
1.2e+00
1.5e+00
—
1.8e+00
1.1e+00
1.0e+00
cases:9.31%
controls:3.33%
cases:6.65%
controls:2.15%
cases:2.44%
controls:0.55%
—
—
cases:3.33%
controls:0.55%
cases:6.96%
controls:2.38%
cases:13.61%
controls:5.23%
42
150
409
4360
30
97
421
4413
11
25
440
4485
—
15
25
436
4483
30
105
401
4301
49
198
311
3585
temazepam; oral
N05CD07 [21604642]
N05CD07 [21604642]
1.0e+00
1.1e+00
1.5e+00
—
1.8e+00
1.2e+00
1.1e+00
cases:8.87%
controls:3.44%
cases:5.32%
controls:1.91%
cases:2.22%
controls:0.51%
—
—
cases:2.66%
controls:0.47%
cases:6.03%
controls:1.84%
cases:9.44%
controls:3.22%
40
155
411
4355
24
86
427
4424
10
23
441
4487
—
12
21
439
4487
26
81
405
4325
34
122
326
3661
quetiapine; oral
N05AH04 [21604544]
N05AH04 [21604544]
1.1e+00
1.3e+00
1.8e+00
—
1.4e+00
1.3e+00
7.9e-01
cases:12.86%
controls:4.75%
cases:10.64%
controls:3.17%
cases:5.32%
controls:0.91%
—
—
cases:4.43%
controls:1.15%
cases:11.83%
controls:3.63%
cases:13.61%
controls:6.69%
58
214
393
4296
48
143
403
4367
24
41
427
4469
—
20
52
431
4456
51
160
380
4246
49
253
311
3530
Essential (primary) hypertension
I10 [45591453]
I10 [45591453]
3.4e-01
4.8e-01
1.0e+00
3.8e+00
1.3e+00
5.8e-01
4.8e-01
cases:26.16%
controls:20.11%
cases:15.30%
controls:10.09%
cases:3.99%
controls:1.44%
cases:4.66%
controls:0.11%
cases:6.21%
controls:1.84%
cases:17.17%
controls:10.37%
cases:36.94%
controls:26.67%
118
907
333
3603
69
455
382
4055
18
65
433
4445
21
5
430
4505
28
83
423
4425
74
457
357
3949
133
1009
227
2774
Lactate [Moles/volume] in Venous blood
2519-7 [3008037]
2519-7 [3008037]
2.4e+00
1.9e+00
—
—
—
1.9e+00
1.3e+00
cases:3.10%
controls:0.29%
cases:2.66%
controls:0.40%
—
—
—
—
—
—
cases:2.32%
controls:0.36%
cases:6.11%
controls:1.67%
14
13
437
4497
12
18
439
4492
—
—
—
10
16
421
4390
22
63
338
3720
Aid fitting and borrowing and monitoring of use
SPAT1230 [2001700331]
SPAT1230 [2001700331]
1.2e+00
1.5e+00
2.3e+00
—
1.6e+00
1.4e+00
1.1e+00
cases:9.09%
controls:2.97%
cases:4.66%
controls:1.09%
cases:1.55%
controls:0.16%
—
—
cases:1.11%
controls:0.22%
cases:4.87%
controls:1.27%
cases:8.61%
controls:2.96%
41
134
410
4376
21
49
430
4461
7
7
444
4503
—
5
10
446
4498
21
56
410
4350
31
112
329
3671
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6768-6 [3035995]
6768-6 [3035995]
4.2e-01
7.2e-01
8.2e-01
3.0e+00
9.9e-01
6.7e-01
8.1e-01
cases:35.25%
controls:26.41%
cases:30.60%
controls:17.67%
cases:8.87%
controls:4.10%
cases:3.99%
controls:0.20%
cases:10.42%
controls:4.13%
cases:30.16%
controls:18.09%
cases:59.72%
controls:39.78%
159
1191
292
3319
138
797
313
3713
40
185
411
4325
18
9
433
4501
47
186
404
4322
130
797
301
3609
215
1505
145
2278
Glucose [Moles/volume] in Venous blood
39480-9 [3038515]
39480-9 [3038515]
2.4e+00
1.9e+00
—
—
—
1.9e+00
1.3e+00
cases:3.10%
controls:0.29%
cases:2.66%
controls:0.40%
—
—
—
—
—
—
cases:2.32%
controls:0.36%
cases:5.28%
controls:1.56%
14
13
437
4497
12
18
439
4492
—
—
—
10
16
421
4390
19
59
341
3724
Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
54067-4 [3051552]
54067-4 [3051552]
1.2e+00
1.7e+00
2.2e+00
—
—
1.5e+00
9.2e-01
cases:3.99%
controls:1.29%
cases:3.55%
controls:0.69%
cases:1.33%
controls:0.16%
—
—
—
—
cases:3.48%
controls:0.79%
cases:6.39%
controls:2.64%
18
58
433
4452
16
31
435
4479
6
7
445
4503
—
—
15
35
416
4371
23
100
337
3683
Methemoglobin/Hemoglobin.total in Blood
2614-6 [3007930]
2614-6 [3007930]
1.7e+00
1.9e+00
—
—
—
2.3e+00
1.6e+00
cases:2.00%
controls:0.38%
cases:2.66%
controls:0.42%
—
—
—
—
—
—
cases:2.78%
controls:0.30%
cases:8.89%
controls:1.98%
9
17
442
4493
12
19
439
4491
—
—
—
12
13
419
4393
32
75
328
3708
Carboxyhemoglobin/Hemoglobin.total in Blood
20563-3 [3023081]
20563-3 [3023081]
1.7e+00
1.8e+00
—
—
—
2.3e+00
1.6e+00
cases:2.00%
controls:0.38%
cases:2.66%
controls:0.44%
—
—
—
—
—
—
cases:2.78%
controls:0.30%
cases:8.89%
controls:1.93%
9
17
442
4493
12
20
439
4490
—
—
—
12
13
419
4393
32
73
328
3710
Case Management Agency
251B00000X [38004193]
251B00000X [38004193]
3.3e-01
5.8e-01
1.1e+00
3.9e+00
1.0e+00
7.4e-01
6.9e-01
cases:87.36%
controls:83.19%
cases:84.70%
controls:75.63%
cases:56.32%
controls:30.98%
cases:48.12%
controls:1.77%
cases:57.21%
controls:31.90%
cases:88.86%
controls:79.21%
cases:97.78%
controls:95.66%
394
3752
57
758
382
3411
69
1099
254
1397
197
3113
217
80
234
4430
258
1438
193
3070
383
3490
48
916
352
3619
8
164
pregabalin; oral
N02BF02 [955152]
N02BF02 [955152]
7.7e-01
1.2e+00
1.5e+00
—
1.6e+00
1.3e+00
9.7e-01
cases:10.64%
controls:5.21%
cases:6.87%
controls:2.26%
cases:2.88%
controls:0.64%
—
—
cases:3.10%
controls:0.64%
cases:8.12%
controls:2.27%
cases:11.39%
controls:4.65%
48
235
403
4275
31
102
420
4408
13
29
438
4481
—
14
29
437
4479
35
100
396
4306
41
176
319
3607
Infectious Disease
44 [38004484]
44 [38004484]
1.1e+00
1.4e+00
2.5e+00
—
—
1.3e+00
9.7e-01
cases:6.21%
controls:2.06%
cases:3.99%
controls:0.98%
cases:1.33%
controls:0.11%
—
—
—
—
cases:3.25%
controls:0.91%
cases:7.78%
controls:3.09%
28
93
423
4417
18
44
433
4466
6
5
445
4505
—
—
14
40
417
4366
28
117
332
3666
Procalcitonin [Mass/volume] in Serum or Plasma
33959-8 [3046279]
33959-8 [3046279]
1.6e+00
2.1e+00
—
—
—
2.5e+00
1.1e+00
cases:2.44%
controls:0.51%
cases:2.44%
controls:0.31%
—
—
—
—
—
—
cases:2.78%
controls:0.23%
cases:4.44%
controls:1.51%
11
23
440
4487
11
14
440
4496
—
—
—
12
10
419
4396
16
57
344
3726
lamotrigine; oral
N03AX09 [21604431]
N03AX09 [21604431]
1.5e+00
2.1e+00
-1.0e+50
—
—
1.7e+00
1.9e+00
cases:3.55%
controls:0.78%
cases:2.88%
controls:0.35%
cases:0.00%
controls:0.18%
—
—
—
—
cases:2.55%
controls:0.45%
cases:5.28%
controls:0.85%
16
35
435
4475
13
16
438
4494
0
8
451
4502
—
—
11
20
420
4386
19
32
341
3751
Plastic And Reconstructive Surgery
24 [38004467]
24 [38004467]
9.4e-01
1.1e+00
1.5e+00
—
2.4e+00
1.7e+00
1.1e+00
cases:7.76%
controls:3.19%
cases:3.55%
controls:1.26%
cases:1.33%
controls:0.31%
—
—
cases:3.33%
controls:0.31%
cases:6.50%
controls:1.20%
cases:10.56%
controls:3.62%
35
144
416
4366
16
57
435
4453
6
14
445
4496
—
15
14
436
4494
28
53
403
4353
38
137
322
3646
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M
62238-1 [40764999]
62238-1 [40764999]
2.9e-01
4.1e-01
1.1e+00
3.5e+00
1.1e+00
4.7e-01
5.6e-01
cases:37.92%
controls:31.31%
cases:37.25%
controls:28.18%
cases:17.07%
controls:6.59%
cases:10.20%
controls:0.33%
cases:17.07%
controls:6.30%
cases:41.53%
controls:30.66%
cases:71.39%
controls:58.71%
171
1412
280
3098
168
1271
283
3239
77
297
374
4213
46
15
405
4495
77
284
374
4224
179
1351
252
3055
257
2221
103
1562
Internal Medicine
11 [38004456]
11 [38004456]
8.0e-01
1.2e+00
1.4e+00
—
1.8e+00
1.1e+00
8.4e-01
cases:38.36%
controls:21.80%
cases:24.17%
controls:8.87%
cases:5.32%
controls:1.40%
—
—
cases:10.42%
controls:1.89%
cases:19.95%
controls:7.56%
cases:33.89%
controls:18.05%
173
983
278
3527
109
400
342
4110
24
63
427
4447
—
47
85
404
4423
86
333
345
4073
122
683
238
3100
Orthopedic Surgery
20 [38004465]
20 [38004465]
5.8e-01
8.7e-01
1.6e+00
—
2.0e+00
1.2e+00
7.3e-01
cases:26.16%
controls:16.52%
cases:14.41%
controls:6.61%
cases:4.66%
controls:0.95%
—
—
cases:8.87%
controls:1.24%
cases:18.10%
controls:6.22%
cases:31.11%
controls:17.84%
118
745
333
3765
65
298
386
4212
21
43
430
4467
—
40
56
411
4452
78
274
353
4132
112
675
248
3108
Emergency Medicine
93 [38004510]
93 [38004510]
6.2e-01
1.0e+00
1.9e+00
—
1.6e+00
9.8e-01
9.5e-01
cases:29.27%
controls:18.14%
cases:24.61%
controls:10.58%
cases:9.76%
controls:1.66%
—
—
cases:7.98%
controls:1.73%
cases:26.22%
controls:11.73%
cases:58.61%
controls:35.42%
132
818
319
3692
111
477
340
4033
44
75
407
4435
—
36
78
415
4430
113
517
318
3889
211
1340
149
2443
Supplier / Service Provider
OMOP5117446 [33004]
OMOP5117446 [33004]
-5.4e-01
-4.3e-01
-2.0e-01
—
2.2e+00
2.7e+00
2.7e+00
cases:17.74%
controls:26.92%
cases:8.20%
controls:12.04%
cases:1.11%
controls:1.35%
—
—
cases:1.33%
controls:0.16%
cases:9.28%
controls:0.70%
cases:20.00%
controls:1.64%
80
1214
371
3296
37
543
414
3967
5
61
446
4449
—
6
7
445
4501
40
31
391
4375
72
62
288
3721
Carbon dioxide [Partial pressure] in Venous blood
2021-4 [3021447]
2021-4 [3021447]
1.3e+00
1.5e+00
1.7e+00
—
1.9e+00
1.2e+00
9.3e-01
cases:6.21%
controls:1.71%
cases:6.43%
controls:1.44%
cases:1.55%
controls:0.29%
—
—
cases:1.77%
controls:0.27%
cases:4.18%
controls:1.34%
cases:11.67%
controls:4.94%
28
77
423
4433
29
65
422
4445
7
13
444
4497
—
8
12
443
4496
18
59
413
4347
42
187
318
3596
tramadol; oral, parenteral, rectal
N02AX02 [21604298]
N02AX02 [21604298]
8.9e-01
9.8e-01
1.7e+00
—
1.5e+00
1.1e+00
6.7e-01
cases:18.18%
controls:8.34%
cases:8.43%
controls:3.33%
cases:2.88%
controls:0.55%
—
—
cases:2.44%
controls:0.53%
cases:7.19%
controls:2.63%
cases:13.33%
controls:7.32%
82
376
369
4134
38
150
413
4360
13
25
438
4485
—
11
24
440
4484
31
116
400
4290
48
277
312
3506
codeine and paracetamol
N02AJ06 [1123647]
N02AJ06 [1123647]
5.6e-01
5.8e-01
1.5e+00
2.7e+00
8.9e-01
7.5e-01
7.6e-01
cases:28.16%
controls:18.23%
cases:11.75%
controls:6.92%
cases:5.32%
controls:1.29%
cases:1.55%
controls:0.11%
cases:2.66%
controls:1.11%
cases:12.53%
controls:6.31%
cases:29.72%
controls:16.55%
127
822
324
3688
53
312
398
4198
24
58
427
4452
7
5
444
4505
12
50
439
4458
54
278
377
4128
107
626
253
3157
MCH [Entitic mass]
28539-5 [3035941]
28539-5 [3035941]
2.0e-01
3.4e-01
1.1e+00
3.7e+00
1.1e+00
4.9e-01
1.9e-01
cases:59.20%
controls:54.35%
cases:54.32%
controls:45.94%
cases:26.83%
controls:10.93%
cases:17.52%
controls:0.51%
cases:26.39%
controls:10.74%
cases:60.56%
controls:48.50%
cases:83.61%
controls:80.89%
267
2451
184
2059
245
2072
206
2438
121
493
330
4017
79
23
372
4487
119
484
332
4024
261
2137
170
2269
301
3060
59
723
Platelets [#/volume] in Blood
26515-7 [3007461]
26515-7 [3007461]
2.1e-01
3.4e-01
1.1e+00
3.7e+00
1.1e+00
4.9e-01
1.9e-01
cases:59.20%
controls:54.17%
cases:54.32%
controls:45.94%
cases:26.83%
controls:10.95%
cases:17.52%
controls:0.51%
cases:26.39%
controls:10.74%
cases:60.56%
controls:48.48%
cases:83.61%
controls:80.78%
267
2443
184
2067
245
2072
206
2438
121
494
330
4016
79
23
372
4487
119
484
332
4024
261
2136
170
2270
301
3056
59
727
MCV [Entitic mean volume] in Red Blood Cells
30428-7 [3024731]
30428-7 [3024731]
2.0e-01
3.3e-01
1.1e+00
3.7e+00
1.1e+00
4.9e-01
2.1e-01
cases:59.20%
controls:54.39%
cases:54.32%
controls:45.99%
cases:26.83%
controls:10.93%
cases:17.52%
controls:0.51%
cases:26.39%
controls:10.74%
cases:60.56%
controls:48.55%
cases:83.89%
controls:80.84%
267
2453
184
2057
245
2074
206
2436
121
493
330
4017
79
23
372
4487
119
484
332
4024
261
2139
170
2267
302
3058
58
725
Leukocytes [#/volume] in Blood
26464-8 [3010813]
26464-8 [3010813]
2.0e-01
3.4e-01
1.1e+00
3.7e+00
1.1e+00
4.9e-01
2.0e-01
cases:59.42%
controls:54.43%
cases:54.55%
controls:46.03%
cases:26.83%
controls:11.00%
cases:17.52%
controls:0.51%
cases:26.39%
controls:10.78%
cases:60.56%
controls:48.55%
cases:83.89%
controls:80.94%
268
2455
183
2055
246
2076
205
2434
121
496
330
4014
79
23
372
4487
119
486
332
4022
261
2139
170
2267
302
3062
58
721
Hematocrit [Volume Fraction] of Blood by calculation
20570-8 [3009542]
20570-8 [3009542]
2.0e-01
3.3e-01
1.1e+00
3.7e+00
1.1e+00
4.9e-01
2.0e-01
cases:59.20%
controls:54.39%
cases:54.32%
controls:46.05%
cases:26.83%
controls:10.95%
cases:17.52%
controls:0.51%
cases:26.39%
controls:10.76%
cases:60.56%
controls:48.50%
cases:83.89%
controls:80.94%
267
2453
184
2057
245
2077
206
2433
121
494
330
4016
79
23
372
4487
119
485
332
4023
261
2137
170
2269
302
3062
58
721
Erythrocytes [#/volume] in Blood
26453-1 [3026361]
26453-1 [3026361]
2.0e-01
3.3e-01
1.1e+00
3.7e+00
1.1e+00
4.9e-01
2.1e-01
cases:59.20%
controls:54.39%
cases:54.32%
controls:46.05%
cases:26.83%
controls:10.95%
cases:17.52%
controls:0.51%
cases:26.39%
controls:10.76%
cases:60.56%
controls:48.52%
cases:83.89%
controls:80.91%
267
2453
184
2057
245
2077
206
2433
121
494
330
4016
79
23
372
4487
119
485
332
4023
261
2138
170
2268
302
3061
58
722
Hemoglobin [Mass/volume] in Blood
718-7 [3000963]
718-7 [3000963]
2.0e-01
3.4e-01
1.1e+00
3.7e+00
1.1e+00
4.9e-01
2.0e-01
cases:59.20%
controls:54.39%
cases:54.55%
controls:46.12%
cases:26.83%
controls:10.98%
cases:17.52%
controls:0.51%
cases:26.39%
controls:10.78%
cases:60.56%
controls:48.59%
cases:83.89%
controls:80.94%
267
2453
184
2057
246
2080
205
2430
121
495
330
4015
79
23
372
4487
119
486
332
4022
261
2141
170
2265
302
3062
58
721
Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
19258-3 [3004529]
19258-3 [3004529]
2.1e+00
1.8e+00
—
—
—
1.7e+00
1.0e+00
cases:4.43%
controls:0.58%
cases:3.77%
controls:0.62%
—
—
—
—
—
—
cases:3.25%
controls:0.59%
cases:7.22%
controls:2.72%
20
26
431
4484
17
28
434
4482
—
—
—
14
26
417
4380
26
103
334
3680
Loss of teeth due to accident, extraction or local periodontal disease
K08.1 [45591573]
K08.1 [45591573]
1.2e+00
1.1e+00
—
1.0e+50
2.7e+00
1.7e+00
1.1e+00
cases:4.66%
controls:1.40%
cases:2.44%
controls:0.80%
—
—
cases:1.33%
controls:0.00%
cases:1.55%
controls:0.11%
cases:3.02%
controls:0.57%
cases:7.50%
controls:2.67%
21
63
430
4447
11
36
440
4474
—
6
0
445
4510
7
5
444
4503
13
25
418
4381
27
101
333
3682
Poisoning by systemic antibiotics
T36 [45756588]
T36 [45756588]
1.9e+00
3.0e+00
—
1.0e+50
—
—
1.7e+00
cases:4.43%
controls:0.69%
cases:3.10%
controls:0.16%
—
—
cases:3.77%
controls:0.00%
—
—
—
—
cases:2.22%
controls:0.40%
20
31
431
4479
14
7
437
4503
—
17
0
434
4510
—
—
8
15
352
3768
Vancomycin [Mass/volume] in Serum or Plasma
20578-1 [3005715]
20578-1 [3005715]
2.3e+00
—
—
—
—
2.7e+00
1.7e+00
cases:1.55%
controls:0.16%
—
—
—
—
—
—
—
—
cases:1.62%
controls:0.11%
cases:2.22%
controls:0.42%
7
7
444
4503
—
—
—
—
7
5
424
4401
8
16
352
3767
Creatinine [Moles/volume] in Serum or Plasma
14682-9 [3020564]
14682-9 [3020564]
2.9e-01
4.5e-01
1.0e+00
3.5e+00
1.1e+00
5.4e-01
3.8e-01
cases:56.10%
controls:48.91%
cases:52.33%
controls:41.26%
cases:23.06%
controls:9.58%
cases:15.96%
controls:0.55%
cases:23.28%
controls:9.07%
cases:56.84%
controls:43.53%
cases:80.56%
controls:73.88%
253
2206
198
2304
236
1861
215
2649
104
432
347
4078
72
25
379
4485
105
409
346
4099
245
1918
186
2488
290
2795
70
988
Blood group antibody screen [Presence] in Serum or Plasma
890-4 [3001079]
890-4 [3001079]
5.5e-01
9.6e-01
1.3e+00
—
2.1e+00
9.7e-01
8.4e-01
cases:18.40%
controls:11.55%
cases:13.53%
controls:5.63%
cases:3.10%
controls:0.91%
—
—
cases:4.66%
controls:0.60%
cases:12.99%
controls:5.38%
cases:33.06%
controls:17.53%
83
521
368
3989
61
254
390
4256
14
41
437
4469
—
21
27
430
4481
56
237
375
4169
119
663
241
3120
Major dressing of wound of skin of lower limb
QDB10 [2001309970]
QDB10 [2001309970]
1.5e+00
1.5e+00
—
1.0e+50
—
2.8e+00
2.3e+00
cases:3.33%
controls:0.73%
cases:1.55%
controls:0.35%
—
—
cases:1.11%
controls:0.00%
—
—
cases:4.18%
controls:0.27%
cases:6.67%
controls:0.69%
15
33
436
4477
7
16
444
4494
—
5
0
446
4510
—
18
12
413
4394
24
26
336
3757
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 [3016431]
19072-8 [3016431]
5.7e-01
9.4e-01
1.4e+00
—
1.8e+00
9.9e-01
9.3e-01
cases:20.40%
controls:12.68%
cases:18.85%
controls:8.34%
cases:5.76%
controls:1.42%
—
—
cases:6.87%
controls:1.24%
cases:20.19%
controls:8.62%
cases:41.94%
controls:22.26%
92
572
359
3938
85
376
366
4134
26
64
425
4446
—
31
56
420
4452
87
380
344
4026
151
842
209
2941
diazepam; oral, parenteral, rectal
N05BA01 [21604566]
N05BA01 [21604566]
7.4e-01
1.1e+00
1.2e+00
—
2.1e+00
1.5e+00
1.3e+00
cases:6.21%
controls:3.06%
cases:3.33%
controls:1.18%
cases:1.11%
controls:0.33%
—
—
cases:2.44%
controls:0.31%
cases:4.41%
controls:1.04%
cases:7.50%
controls:2.22%
28
138
423
4372
15
53
436
4457
5
15
446
4495
—
11
14
440
4494
19
46
412
4360
27
84
333
3699
Physical Medicine And Rehabilitation
25 [38004468]
25 [38004468]
7.1e-01
1.3e+00
1.3e+00
—
2.0e+00
1.5e+00
1.1e+00
cases:13.30%
controls:6.98%
cases:10.20%
controls:2.86%
cases:2.44%
controls:0.71%
—
—
cases:3.33%
controls:0.47%
cases:11.14%
controls:2.77%
cases:19.72%
controls:7.67%
60
315
391
4195
46
129
405
4381
11
32
440
4478
—
15
21
436
4487
48
122
383
4284
71
290
289
3493
Endocrinology
46 [38004485]
46 [38004485]
8.4e-01
8.0e-01
1.4e+00
—
1.6e+00
9.7e-01
1.0e+00
cases:9.53%
controls:4.37%
cases:5.76%
controls:2.68%
cases:2.66%
controls:0.69%
—
—
cases:3.33%
controls:0.69%
cases:6.26%
controls:2.47%
cases:13.33%
controls:5.21%
43
197
408
4313
26
121
425
4389
12
31
439
4479
—
15
31
436
4477
27
109
404
4297
48
197
312
3586
Outpatient Hospital
22 [8756]
22 [8756]
5.5e-01
9.2e-01
1.4e+00
—
1.8e+00
1.0e+00
9.7e-01
cases:39.25%
controls:27.23%
cases:17.07%
controls:7.61%
cases:4.21%
controls:1.06%
—
—
cases:5.54%
controls:1.00%
cases:14.85%
controls:6.01%
cases:21.39%
controls:9.33%
177
1228
274
3282
77
343
374
4167
19
48
432
4462
—
25
45
426
4463
64
265
367
4141
77
353
283
3430
Erythrocyte [DistWidth] in Red Blood Cells
30385-9 [3002385]
30385-9 [3002385]
5.8e-02
2.8e-01
9.6e-01
3.5e+00
1.1e+00
5.3e-01
5.5e-01
cases:33.04%
controls:31.77%
cases:33.70%
controls:27.74%
cases:16.19%
controls:6.90%
cases:11.53%
controls:0.40%
cases:16.85%
controls:6.43%
cases:41.76%
controls:29.60%
cases:67.50%
controls:54.48%
149
1433
302
3077
152
1251
299
3259
73
311
378
4199
52
18
399
4492
76
290
375
4218
180
1304
251
3102
243
2061
117
1722
cefalexin; oral
J01DB01 [21602870]
J01DB01 [21602870]
6.8e-01
1.0e+00
1.7e+00
—
1.9e+00
7.4e-01
6.2e-01
cases:47.45%
controls:31.49%
cases:23.28%
controls:9.98%
cases:5.32%
controls:1.04%
—
—
cases:5.99%
controls:0.98%
cases:17.63%
controls:9.31%
cases:40.00%
controls:26.30%
214
1420
237
3090
105
450
346
4060
24
47
427
4463
—
27
44
424
4464
76
410
355
3996
144
995
216
2788
Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
30248-9 [3015399]
30248-9 [3015399]
7.1e-01
1.0e+00
1.6e+00
—
1.6e+00
9.9e-01
5.6e-01
cases:11.53%
controls:6.01%
cases:8.20%
controls:3.15%
cases:1.77%
controls:0.35%
—
—
cases:2.00%
controls:0.42%
cases:7.89%
controls:3.09%
cases:18.61%
controls:11.58%
52
271
399
4239
37
142
414
4368
8
16
443
4494
—
9
19
442
4489
34
136
397
4270
67
438
293
3345
buprenorphine; parenteral, sublingual, transdermal
N02AE01 [21604287]
N02AE01 [21604287]
1.2e+00
1.2e+00
1.8e+00
—
1.2e+00
1.2e+00
1.1e+00
cases:5.76%
controls:1.88%
cases:3.77%
controls:1.15%
cases:2.22%
controls:0.38%
—
—
cases:1.33%
controls:0.40%
cases:4.87%
controls:1.57%
cases:9.44%
controls:3.46%
26
85
425
4425
17
52
434
4458
10
17
441
4493
—
6
18
445
4490
21
69
410
4337
34
131
326
3652
Limited function/disability (L)
L28 [2002000647]
L28 [2002000647]
7.0e-01
1.5e+00
2.5e+00
—
—
1.3e+00
1.1e+00
cases:6.21%
controls:3.17%
cases:4.43%
controls:1.04%
cases:1.33%
controls:0.11%
—
—
—
—
cases:5.34%
controls:1.50%
cases:12.78%
controls:4.65%
28
143
423
4367
20
47
431
4463
6
5
445
4505
—
—
23
66
408
4340
46
176
314
3607
Type 1 diabetes mellitus, With multiple complications
E10.7 [45571655]
E10.7 [45571655]
1.1e+00
1.3e+00
2.3e+00
1.0e+50
2.7e+00
1.4e+00
9.8e-01
cases:2.66%
controls:0.86%
cases:2.22%
controls:0.64%
cases:1.55%
controls:0.16%
cases:1.11%
controls:0.00%
cases:1.55%
controls:0.11%
cases:2.78%
controls:0.70%
cases:2.78%
controls:1.06%
12
39
439
4471
10
29
441
4481
7
7
444
4503
5
0
446
4510
7
5
444
4503
12
31
419
4375
10
40
350
3743
Emergency Room and Inpatient Visit
ERIP [262]
ERIP [262]
3.0e-01
1.1e+00
2.0e+00
—
1.4e+00
1.0e+00
7.9e-01
cases:6.21%
controls:4.68%
cases:10.64%
controls:3.88%
cases:3.99%
controls:0.53%
—
—
cases:3.10%
controls:0.78%
cases:11.83%
controls:4.56%
cases:31.39%
controls:17.26%
28
211
423
4299
48
175
403
4335
18
24
433
4486
—
14
35
437
4473
51
201
380
4205
113
653
247
3130
Depressive episode, unspecified
F32.9 [45571760]
F32.9 [45571760]
8.5e-01
1.5e+00
2.0e+00
—
2.4e+00
1.2e+00
1.0e+00
cases:4.43%
controls:1.95%
cases:3.33%
controls:0.75%
cases:1.11%
controls:0.16%
—
—
cases:2.00%
controls:0.18%
cases:3.02%
controls:0.89%
cases:7.22%
controls:2.78%
20
88
431
4422
15
34
436
4476
5
7
446
4503
—
9
8
442
4500
13
39
418
4367
26
105
334
3678
Glucose [Moles/volume] in Serum or Plasma
14749-6 [3013826]
14749-6 [3013826]
5.2e-01
9.5e-01
1.4e+00
—
1.5e+00
9.5e-01
9.2e-01
cases:24.17%
controls:15.96%
cases:20.84%
controls:9.22%
cases:6.43%
controls:1.71%
—
—
cases:5.99%
controls:1.46%
cases:20.42%
controls:9.01%
cases:48.89%
controls:27.62%
109
720
342
3790
94
416
357
4094
29
77
422
4433
—
27
66
424
4442
88
397
343
4009
176
1045
184
2738
Bacterial infection, unspecified
A49.9 [45590816]
A49.9 [45590816]
1.8e+00
1.5e+00
—
—
—
1.6e+00
1.2e+00
cases:6.65%
controls:1.15%
cases:3.10%
controls:0.71%
—
—
—
—
—
—
cases:2.32%
controls:0.45%
cases:6.39%
controls:2.01%
30
52
421
4458
14
32
437
4478
—
—
—
10
20
421
4386
23
76
337
3707
Home Visit
OMOP4822459 [581476]
OMOP4822459 [581476]
6.7e-01
1.0e+00
1.2e+00
8.8e-01
1.4e+00
9.8e-01
8.6e-01
cases:13.97%
controls:7.69%
cases:11.09%
controls:4.21%
cases:5.10%
controls:1.57%
cases:1.33%
controls:0.55%
cases:6.21%
controls:1.60%
cases:11.83%
controls:4.81%
cases:26.11%
controls:13.03%
63
347
388
4163
50
190
401
4320
23
71
428
4439
6
25
445
4485
28
72
423
4436
51
212
380
4194
94
493
266
3290
General Practice Dentistry
1223G0001X [38003675]
1223G0001X [38003675]
1.3e+00
2.1e+00
—
1.0e+50
—
2.7e+00
1.1e+00
cases:2.66%
controls:0.71%
cases:1.77%
controls:0.22%
—
—
cases:1.33%
controls:0.00%
—
—
cases:2.55%
controls:0.18%
cases:1.94%
controls:0.69%
12
32
439
4478
8
10
443
4500
—
6
0
445
4510
—
11
8
420
4398
7
26
353
3757
ANTIHYPERTENSIVE_DRUG - yes
ANTIHYPERTENSIVE_DRUG-1 [2002330215]
ANTIHYPERTENSIVE_DRUG-1 [2002330215]
1.9e+00
1.8e+00
—
—
—
1.7e+00
2.4e+00
cases:2.44%
controls:0.38%
cases:1.77%
controls:0.29%
—
—
—
—
—
—
cases:1.62%
controls:0.30%
cases:2.50%
controls:0.24%
11
17
440
4493
8
13
443
4497
—
—
—
7
13
424
4393
9
9
351
3774
Transferrin [Mass/volume] in Serum or Plasma
3034-6 [3004789]
3034-6 [3004789]
9.4e-01
1.0e+00
—
—
2.0e+00
1.1e+00
1.0e+00
cases:6.65%
controls:2.71%
cases:4.88%
controls:1.80%
—
—
—
—
cases:2.00%
controls:0.27%
cases:5.57%
controls:1.97%
cases:16.67%
controls:6.79%
30
122
421
4388
22
81
429
4429
—
—
9
12
442
4496
24
87
407
4319
60
257
300
3526
Infection following a procedure, not elsewhere classified
T81.4 [45575538]
T81.4 [45575538]
1.1e+00
1.6e+00
—
1.0e+50
—
1.8e+00
1.5e+00
cases:3.10%
controls:1.06%
cases:2.00%
controls:0.40%
—
—
cases:1.33%
controls:0.00%
—
—
cases:1.86%
controls:0.32%
cases:5.56%
controls:1.32%
14
48
437
4462
9
18
442
4492
—
6
0
445
4510
—
8
14
423
4392
20
50
340
3733
Sampling
SPAT1263 [2001700364]
SPAT1263 [2001700364]
7.3e-01
8.2e-01
1.5e+00
—
1.2e+00
1.1e+00
6.2e-01
cases:24.61%
controls:13.59%
cases:12.20%
controls:5.76%
cases:3.55%
controls:0.80%
—
—
cases:2.88%
controls:0.89%
cases:13.46%
controls:5.02%
cases:23.89%
controls:14.41%
111
613
340
3897
55
260
396
4250
16
36
435
4474
—
13
40
438
4468
58
221
373
4185
86
545
274
3238
Iron [Moles/volume] in Serum or Plasma
14798-3 [3022948]
14798-3 [3022948]
1.0e+00
9.9e-01
1.5e+00
—
2.0e+00
1.1e+00
9.5e-01
cases:7.54%
controls:2.90%
cases:4.88%
controls:1.86%
cases:1.33%
controls:0.29%
—
—
cases:2.00%
controls:0.29%
cases:5.80%
controls:2.09%
cases:17.50%
controls:7.56%
34
131
417
4379
22
84
429
4426
6
13
445
4497
—
9
13
442
4495
25
92
406
4314
63
286
297
3497
Telephone, letter or other consultation without direct patient contact
ZY020 [2001311600]
ZY020 [2001311600]
1.5e+00
1.4e+00
—
—
—
2.1e+00
2.4e+00
cases:4.66%
controls:1.06%
cases:1.77%
controls:0.44%
—
—
—
—
—
—
cases:2.09%
controls:0.27%
cases:4.44%
controls:0.42%
21
48
430
4462
8
20
443
4490
—
—
—
9
12
422
4394
16
16
344
3767
Iron/Transferrin [Ratio] in Serum or Plasma
60517-0 [40763571]
60517-0 [40763571]
9.7e-01
1.1e+00
1.4e+00
—
1.8e+00
1.1e+00
9.8e-01
cases:6.21%
controls:2.44%
cases:4.66%
controls:1.66%
cases:1.11%
controls:0.27%
—
—
cases:1.77%
controls:0.29%
cases:5.34%
controls:1.82%
cases:15.28%
controls:6.34%
28
110
423
4400
21
75
430
4435
5
12
446
4498
—
8
13
443
4495
23
80
408
4326
55
240
305
3543
Albumin [Mass/volume] in Serum or Plasma
1751-7 [3024561]
1751-7 [3024561]
5.6e-01
7.7e-01
1.4e+00
—
1.6e+00
9.4e-01
7.3e-01
cases:18.40%
controls:11.42%
cases:14.41%
controls:7.25%
cases:5.54%
controls:1.49%
—
—
cases:5.32%
controls:1.18%
cases:16.94%
controls:7.35%
cases:33.61%
controls:19.56%
83
515
368
3995
65
327
386
4183
25
67
426
4443
—
24
53
427
4455
73
324
358
4082
121
740
239
3043
Folate [Moles/volume] in Serum or Plasma
14732-2 [3021960]
14732-2 [3021960]
2.0e-01
8.5e-01
2.0e+00
—
2.2e+00
8.6e-01
4.1e-01
cases:3.33%
controls:2.73%
cases:4.66%
controls:2.04%
cases:1.77%
controls:0.24%
—
—
cases:1.77%
controls:0.20%
cases:6.50%
controls:2.86%
cases:19.72%
controls:13.98%
15
123
436
4387
21
92
430
4418
8
11
443
4499
—
8
9
443
4499
28
126
403
4280
71
529
289
3254
Treatment plan or consultation
WZC00 [2001310885]
WZC00 [2001310885]
5.2e-01
1.2e+00
1.2e+00
—
1.6e+00
1.6e+00
9.1e-01
cases:12.42%
controls:7.76%
cases:9.09%
controls:2.79%
cases:1.33%
controls:0.42%
—
—
cases:2.44%
controls:0.51%
cases:11.14%
controls:2.38%
cases:18.89%
controls:8.54%
56
350
395
4160
41
126
410
4384
6
19
445
4491
—
11
23
440
4485
48
105
383
4301
68
323
292
3460
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
47598-8 [3048816]
47598-8 [3048816]
5.2e-01
1.1e+00
2.2e+00
—
1.4e+00
1.7e+00
9.7e-01
cases:2.66%
controls:1.60%
cases:3.55%
controls:1.22%
cases:1.33%
controls:0.16%
—
—
cases:1.11%
controls:0.27%
cases:5.10%
controls:1.00%
cases:7.50%
controls:2.99%
12
72
439
4438
16
55
435
4455
6
7
445
4503
—
5
12
446
4496
22
44
409
4362
27
113
333
3670
Clinical & Laboratory Dermatological Immunology Physician
207NI0002X [38003841]
207NI0002X [38003841]
7.4e-01
5.9e-01
1.4e+00
1.0e+50
1.5e+00
1.5e+00
7.1e-01
cases:15.08%
controls:7.83%
cases:6.43%
controls:3.68%
cases:2.22%
controls:0.55%
cases:6.21%
controls:0.00%
cases:3.33%
controls:0.75%
cases:12.99%
controls:3.18%
cases:16.67%
controls:8.96%
68
353
383
4157
29
166
422
4344
10
25
441
4485
28
0
423
4510
15
34
436
4474
56
140
375
4266
60
339
300
3444
Blood type and Crossmatch panel - Blood
34531-4 [3044640]
34531-4 [3044640]
5.0e-01
9.7e-01
1.2e+00
—
2.6e+00
1.2e+00
5.7e-01
cases:13.75%
controls:8.80%
cases:10.20%
controls:4.12%
cases:2.22%
controls:0.67%
—
—
cases:4.43%
controls:0.35%
cases:11.14%
controls:3.50%
cases:18.89%
controls:11.60%
62
397
389
4113
46
186
405
4324
10
30
441
4480
—
20
16
431
4492
48
154
383
4252
68
439
292
3344
Suture or treatment of traumatic wound
SPAT1149 [2001700250]
SPAT1149 [2001700250]
1.1e+00
1.4e+00
—
—
—
1.9e+00
1.4e+00
cases:7.76%
controls:2.71%
cases:3.10%
controls:0.78%
—
—
—
—
—
—
cases:3.94%
controls:0.59%
cases:6.11%
controls:1.64%
35
122
416
4388
14
35
437
4475
—
—
—
17
26
414
4380
22
62
338
3721
pH of Serum or Plasma
2753-2 [3018418]
2753-2 [3018418]
1.8e-01
6.3e-01
1.7e+00
—
1.8e+00
8.9e-01
7.2e-01
cases:8.65%
controls:7.34%
cases:8.65%
controls:4.81%
cases:3.99%
controls:0.75%
—
—
cases:3.77%
controls:0.62%
cases:11.14%
controls:4.88%
cases:21.94%
controls:12.00%
39
331
412
4179
39
217
412
4293
18
34
433
4476
—
17
28
434
4480
48
215
383
4191
79
454
281
3329
Calcium.ionized [Moles/volume] in Serum or Plasma
1995-0 [3021347]
1995-0 [3021347]
4.1e-01
9.1e-01
1.4e+00
—
1.7e+00
9.5e-01
7.9e-01
cases:16.63%
controls:11.71%
cases:16.41%
controls:7.29%
cases:5.10%
controls:1.31%
—
—
cases:5.32%
controls:1.02%
cases:17.40%
controls:7.51%
cases:33.06%
controls:18.32%
75
528
376
3982
74
329
377
4181
23
59
428
4451
—
24
46
427
4462
75
331
356
4075
119
693
241
3090
oxycodone and naloxone; oral
N02AA55 [21604265]
N02AA55 [21604265]
1.0e+00
7.4e-01
1.5e+00
—
2.1e+00
1.5e+00
1.1e+00
cases:5.10%
controls:1.86%
cases:2.44%
controls:1.18%
cases:1.33%
controls:0.31%
—
—
cases:2.44%
controls:0.31%
cases:4.64%
controls:1.09%
cases:13.33%
controls:4.73%
23
84
428
4426
11
53
440
4457
6
14
445
4496
—
11
14
440
4494
20
48
411
4358
48
179
312
3604
Microscopic observation [Identifier] in Isolate by Gram stain
87975-9 [36305247]
87975-9 [36305247]
2.1e+00
—
—
—
—
1.8e+00
1.8e+00
cases:1.55%
controls:0.20%
—
—
—
—
—
—
—
—
cases:2.09%
controls:0.34%
cases:5.00%
controls:0.85%
7
9
444
4501
—
—
—
—
9
15
422
4391
18
32
342
3751
prazosin; oral
C02CA01 [21600411]
C02CA01 [21600411]
2.0e+00
1.5e+00
—
—
—
1.9e+00
1.8e+00
cases:2.22%
controls:0.31%
cases:1.11%
controls:0.24%
—
—
—
—
—
—
cases:1.86%
controls:0.27%
cases:2.78%
controls:0.48%
10
14
441
4496
5
11
446
4499
—
—
—
8
12
423
4394
10
18
350
3765
Troponin T.cardiac [Mass/volume] in Serum or Plasma
6598-7 [3019800]
6598-7 [3019800]
6.1e-01
9.5e-01
1.5e+00
—
1.3e+00
8.5e-01
5.2e-01
cases:18.18%
controls:10.80%
cases:13.30%
controls:5.61%
cases:3.55%
controls:0.80%
—
—
cases:3.77%
controls:1.11%
cases:11.60%
controls:5.29%
cases:26.67%
controls:17.84%
82
487
369
4023
60
253
391
4257
16
36
435
4474
—
17
50
434
4458
50
233
381
4173
96
675
264
3108
oxazepam; oral
N05BA04 [21604569]
N05BA04 [21604569]
7.2e-01
8.4e-01
1.4e+00
—
1.2e+00
7.5e-01
7.1e-01
cases:11.09%
controls:5.70%
cases:7.32%
controls:3.30%
cases:2.88%
controls:0.71%
—
—
cases:2.88%
controls:0.87%
cases:7.42%
controls:3.65%
cases:12.50%
controls:6.56%
50
257
401
4253
33
149
418
4361
13
32
438
4478
—
13
39
438
4469
32
161
399
4245
45
248
315
3535
Oxygen [Partial pressure] in Venous blood
2705-2 [3024354]
2705-2 [3024354]
1.6e+00
1.6e+00
1.7e+00
—
1.7e+00
1.4e+00
1.1e+00
cases:6.21%
controls:1.33%
cases:5.32%
controls:1.11%
cases:1.11%
controls:0.20%
—
—
cases:1.11%
controls:0.20%
cases:3.71%
controls:0.93%
cases:10.83%
controls:4.07%
28
60
423
4450
24
50
427
4460
5
9
446
4501
—
5
9
446
4499
16
41
415
4365
39
154
321
3629
ABO and Rh group [Type] in Blood by Confirmatory method
77397-8 [46236098]
77397-8 [46236098]
4.7e-01
7.9e-01
1.5e+00
1.0e+50
2.4e+00
9.7e-01
4.4e-01
cases:8.43%
controls:5.43%
cases:5.54%
controls:2.59%
cases:2.22%
controls:0.51%
cases:2.00%
controls:0.00%
cases:2.66%
controls:0.24%
cases:6.50%
controls:2.56%
cases:13.61%
controls:9.23%
38
245
413
4265
25
117
426
4393
10
23
441
4487
9
0
442
4510
12
11
439
4497
28
113
403
4293
49
349
311
3434
Erysipelas
A46 [45561706]
A46 [45561706]
1.1e+00
1.5e+00
2.0e+00
—
—
9.1e-01
9.8e-01
cases:6.43%
controls:2.15%
cases:3.33%
controls:0.75%
cases:1.33%
controls:0.18%
—
—
—
—
cases:2.55%
controls:1.04%
cases:7.78%
controls:3.07%
29
97
422
4413
15
34
436
4476
6
8
445
4502
—
—
11
46
420
4360
28
116
332
3667
Other specified counselling
Z71.8 [45581061]
Z71.8 [45581061]
6.7e-01
1.1e+00
1.1e+00
1.0e+50
2.0e+00
1.1e+00
7.5e-01
cases:9.98%
controls:5.37%
cases:7.76%
controls:2.79%
cases:1.11%
controls:0.35%
cases:1.33%
controls:0.00%
cases:2.88%
controls:0.40%
cases:8.35%
controls:2.86%
cases:22.78%
controls:12.21%
45
242
406
4268
35
126
416
4384
5
16
446
4494
6
0
445
4510
13
18
438
4490
36
126
395
4280
82
462
278
3321
Pharmacy visit
OMOP4822462 [581458]
OMOP4822462 [581458]
7.5e-01
1.0e+00
7.9e-01
1.9e+00
9.4e-01
8.1e-01
2.3e+00
cases:98.45%
controls:96.76%
cases:95.79%
controls:88.85%
cases:70.07%
controls:51.55%
cases:16.41%
controls:2.73%
cases:72.95%
controls:51.35%
cases:94.66%
controls:88.74%
cases:99.72%
controls:97.28%
444
4364
7
146
432
4007
19
503
316
2325
135
2185
74
123
377
4387
329
2315
122
2193
408
3910
23
496
359
3680
1
103
calcium carbonate
A02AC01 [21600065]
A02AC01 [21600065]
1.6e+00
2.0e+00
—
—
—
1.5e+00
1.8e+00
cases:2.00%
controls:0.40%
cases:1.77%
controls:0.24%
—
—
—
—
—
—
cases:1.39%
controls:0.32%
cases:2.78%
controls:0.45%
9
18
442
4492
8
11
443
4499
—
—
—
6
14
425
4392
10
17
350
3766
calcium carbonate; oral
A12AA04 [21600863]
A12AA04 [21600863]
1.6e+00
2.0e+00
—
—
—
1.5e+00
1.8e+00
cases:2.00%
controls:0.40%
cases:1.77%
controls:0.24%
—
—
—
—
—
—
cases:1.39%
controls:0.32%
cases:2.78%
controls:0.45%
9
18
442
4492
8
11
443
4499
—
—
—
6
14
425
4392
10
17
350
3766
Bilirubin.total [Moles/volume] in Serum or Plasma
14631-6 [3006140]
14631-6 [3006140]
5.5e-01
1.0e+00
9.8e-01
—
1.1e+00
8.9e-01
8.5e-01
cases:21.73%
controls:13.75%
cases:19.96%
controls:8.14%
cases:5.32%
controls:2.06%
—
—
cases:6.21%
controls:2.20%
cases:18.79%
controls:8.65%
cases:42.22%
controls:23.74%
98
620
353
3890
90
367
361
4143
24
93
427
4417
—
28
99
423
4409
81
381
350
4025
152
898
208
2885
No procedures
SPAT1301 [2001700402]
SPAT1301 [2001700402]
8.0e-01
1.2e+00
1.1e+00
—
1.7e+00
9.2e-01
7.3e-01
cases:18.63%
controls:9.33%
cases:9.53%
controls:3.13%
cases:2.00%
controls:0.67%
—
—
cases:3.55%
controls:0.67%
cases:7.89%
controls:3.31%
cases:15.28%
controls:8.01%
84
421
367
4089
43
141
408
4369
9
30
442
4480
—
16
30
435
4478
34
146
397
4260
55
303
305
3480
Erythrocytes [Presence] in Urine by Automated
53292-9 [3041096]
53292-9 [3041096]
6.2e-01
9.5e-01
9.9e-01
—
2.1e+00
7.8e-01
8.5e-01
cases:13.08%
controls:7.47%
cases:10.86%
controls:4.50%
cases:1.77%
controls:0.67%
—
—
cases:3.55%
controls:0.47%
cases:9.28%
controls:4.47%
cases:25.83%
controls:13.01%
59
337
392
4173
49
203
402
4307
8
30
443
4480
—
16
21
435
4487
40
197
391
4209
93
492
267
3291
Osmolality of Urine
2695-5 [3026782]
2695-5 [3026782]
7.3e-01
8.8e-01
1.2e+00
—
1.5e+00
1.1e+00
1.0e+00
cases:12.42%
controls:6.41%
cases:7.54%
controls:3.28%
cases:1.55%
controls:0.49%
—
—
cases:2.66%
controls:0.62%
cases:7.19%
controls:2.47%
cases:16.94%
controls:6.93%
56
289
395
4221
34
148
417
4362
7
22
444
4488
—
12
28
439
4480
31
109
400
4297
61
262
299
3521
Laboratory Visit
OMOP4822461 [32036]
OMOP4822461 [32036]
1.0e-01
2.7e-01
9.6e-01
3.3e+00
9.1e-01
3.1e-01
5.7e-02
cases:63.41%
controls:60.98%
cases:63.41%
controls:57.05%
cases:37.92%
controls:18.98%
cases:22.62%
controls:1.04%
cases:36.14%
controls:18.52%
cases:68.21%
controls:61.17%
cases:87.22%
controls:86.57%
286
2750
165
1760
286
2573
165
1937
171
856
280
3654
102
47
349
4463
163
835
288
3673
294
2695
137
1711
314
3275
46
508
Inpatient Visit
IP [9201]
IP [9201]
5.3e-01
1.3e+00
1.2e+00
—
1.8e+00
1.2e+00
8.1e-01
cases:7.98%
controls:4.88%
cases:10.20%
controls:3.08%
cases:2.00%
controls:0.60%
—
—
cases:3.10%
controls:0.51%
cases:11.60%
controls:3.65%
cases:27.22%
controls:14.25%
36
220
415
4290
46
139
405
4371
9
27
442
4483
—
14
23
437
4485
50
161
381
4245
98
539
262
3244
olanzapine; oral, parenteral
N05AH03 [21604543]
N05AH03 [21604543]
1.1e+00
1.2e+00
7.4e-01
—
1.6e+00
1.4e+00
1.4e+00
cases:3.77%
controls:1.26%
cases:3.33%
controls:1.06%
cases:1.11%
controls:0.53%
—
—
cases:1.55%
controls:0.33%
cases:3.71%
controls:0.98%
cases:6.11%
controls:1.59%
17
57
434
4453
15
48
436
4462
5
24
446
4486
—
7
15
444
4493
16
43
415
4363
22
60
338
3723
MCHC [Entitic Mass/volume] in Red Blood Cells
28540-3 [3003338]
28540-3 [3003338]
8.4e-02
1.6e-01
8.4e-01
3.3e+00
9.2e-01
1.6e-01
-2.1e-01
cases:42.79%
controls:40.75%
cases:35.48%
controls:31.86%
cases:15.30%
controls:7.25%
cases:9.53%
controls:0.40%
cases:15.74%
controls:6.90%
cases:36.66%
controls:33.00%
cases:54.17%
controls:59.29%
193
1838
258
2672
160
1437
291
3073
69
327
382
4183
43
18
408
4492
71
311
380
4197
158
1454
273
2952
195
2243
165
1540
Extended examination of mouth
SAA03 [2001310276]
SAA03 [2001310276]
3.7e-01
9.9e-01
2.0e+00
1.0e+50
—
1.4e+00
6.6e-01
cases:17.52%
controls:12.82%
cases:6.87%
controls:2.66%
cases:1.55%
controls:0.22%
cases:5.99%
controls:0.00%
—
—
cases:7.42%
controls:1.91%
cases:13.06%
controls:7.22%
79
578
372
3932
31
120
420
4390
7
10
444
4500
27
0
424
4510
—
32
84
399
4322
47
273
313
3510
General symptom/complaint other
A29 [2002000163]
A29 [2002000163]
7.6e-01
1.0e+00
—
—
2.7e+00
1.5e+00
9.1e-01
cases:5.32%
controls:2.55%
cases:2.66%
controls:0.95%
—
—
—
—
cases:1.55%
controls:0.11%
cases:3.71%
controls:0.89%
cases:7.22%
controls:3.04%
24
115
427
4395
12
43
439
4467
—
—
7
5
444
4503
16
39
415
4367
26
115
334
3668
Urinalysis macro (dipstick) panel - Urine
24357-6 [3037467]
24357-6 [3037467]
6.1e-01
7.3e-01
1.2e+00
—
1.3e+00
5.0e-01
6.1e-01
cases:35.92%
controls:23.35%
cases:24.83%
controls:13.77%
cases:6.21%
controls:1.93%
—
—
cases:6.65%
controls:1.84%
cases:20.42%
controls:13.46%
cases:48.33%
controls:33.65%
162
1053
289
3457
112
621
339
3889
28
87
423
4423
—
30
83
421
4425
88
593
343
3813
174
1273
186
2510
Insertion of central venous catheter through external or internal jugular vein
TPH15 [2001309600]
TPH15 [2001309600]
1.3e+00
—
—
—
—
2.0e+00
1.6e+00
cases:2.88%
controls:0.80%
—
—
—
—
—
—
—
—
cases:1.62%
controls:0.23%
cases:3.33%
controls:0.69%
13
36
438
4474
—
—
—
—
7
10
424
4396
12
26
348
3757
Differential panel, method unspecified - Blood
69738-3 [42870588]
69738-3 [42870588]
4.9e-01
6.3e-01
1.2e+00
—
1.5e+00
7.7e-01
7.7e-01
cases:13.53%
controls:8.76%
cases:11.31%
controls:6.39%
cases:5.10%
controls:1.60%
—
—
cases:5.76%
controls:1.38%
cases:12.99%
controls:6.47%
cases:25.56%
controls:13.75%
61
395
390
4115
51
288
400
4222
23
72
428
4438
—
26
62
425
4446
56
285
375
4121
92
520
268
3263
Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
13317-3 [3019902]
13317-3 [3019902]
8.8e-01
1.3e+00
—
—
1.1e+00
1.4e+00
1.2e+00
cases:5.76%
controls:2.48%
cases:4.88%
controls:1.37%
—
—
—
—
cases:1.11%
controls:0.35%
cases:4.64%
controls:1.20%
cases:10.00%
controls:3.09%
26
112
425
4398
22
62
429
4448
—
—
5
16
446
4492
20
53
411
4353
36
117
324
3666
Eosinophils/Leukocytes in Blood
26450-7 [3006504]
26450-7 [3006504]
3.7e-01
6.9e-01
1.2e+00
—
1.4e+00
6.6e-01
8.2e-01
cases:18.85%
controls:13.81%
cases:16.63%
controls:9.07%
cases:7.10%
controls:2.20%
—
—
cases:7.10%
controls:1.86%
cases:16.24%
controls:9.12%
cases:37.50%
controls:20.86%
85
623
366
3887
75
409
376
4101
32
99
419
4411
—
32
84
419
4424
70
402
361
4004
135
789
225
2994
prednisolone
A07EA01 [21600653]
A07EA01 [21600653]
7.4e-01
7.9e-01
2.9e-01
1.0e+50
1.8e+00
7.7e-01
7.3e-01
cases:22.84%
controls:12.39%
cases:12.64%
controls:6.19%
cases:1.77%
controls:1.33%
cases:1.11%
controls:0.00%
cases:5.32%
controls:0.95%
cases:11.37%
controls:5.58%
cases:24.72%
controls:13.69%
103
559
348
3951
57
279
394
4231
8
60
443
4450
5
0
446
4510
24
43
427
4465
49
246
382
4160
89
518
271
3265
prednisolone; oral, parenteral
H02AB06 [21602734]
H02AB06 [21602734]
7.5e-01
7.4e-01
2.9e-01
1.0e+50
1.8e+00
7.9e-01
7.3e-01
cases:22.84%
controls:12.28%
cases:12.20%
controls:6.19%
cases:1.77%
controls:1.33%
cases:1.11%
controls:0.00%
cases:5.32%
controls:0.95%
cases:11.37%
controls:5.52%
cases:24.72%
controls:13.64%
103
554
348
3956
55
279
396
4231
8
60
443
4450
5
0
446
4510
24
43
427
4465
49
243
382
4163
89
516
271
3267
Monocytes/Leukocytes in Blood
26485-3 [3019069]
26485-3 [3019069]
3.7e-01
6.9e-01
1.2e+00
—
1.4e+00
6.7e-01
8.0e-01
cases:18.85%
controls:13.81%
cases:16.63%
controls:9.07%
cases:7.10%
controls:2.20%
—
—
cases:7.10%
controls:1.89%
cases:16.47%
controls:9.15%
cases:36.94%
controls:20.91%
85
623
366
3887
75
409
376
4101
32
99
419
4411
—
32
85
419
4423
71
403
360
4003
133
791
227
2992
Bacteria identified in Urine by Culture
630-4 [3026008]
630-4 [3026008]
6.9e-01
1.0e+00
1.4e+00
—
1.6e+00
6.9e-01
7.8e-01
cases:14.63%
controls:7.92%
cases:10.86%
controls:4.26%
cases:1.77%
controls:0.44%
—
—
cases:2.66%
controls:0.55%
cases:9.05%
controls:4.74%
cases:25.83%
controls:13.77%
66
357
385
4153
49
192
402
4318
8
20
443
4490
—
12
25
439
4483
39
209
392
4197
93
521
267
3262
Basophils/Leukocytes in Blood
30180-4 [3022096]
30180-4 [3022096]
3.8e-01
7.0e-01
1.2e+00
—
1.4e+00
6.6e-01
8.0e-01
cases:18.85%
controls:13.75%
cases:16.63%
controls:8.98%
cases:6.87%
controls:2.20%
—
—
cases:7.10%
controls:1.84%
cases:16.24%
controls:9.15%
cases:37.22%
controls:20.96%
85
620
366
3890
75
405
376
4105
31
99
420
4411
—
32
83
419
4425
70
403
361
4003
134
793
226
2990
Observation for suspected disease or condition, unspecified
Z03.9 [45552062]
Z03.9 [45552062]
8.5e-01
1.1e+00
1.7e+00
—
—
1.5e+00
1.2e+00
cases:7.32%
controls:3.26%
cases:3.55%
controls:1.18%
cases:1.11%
controls:0.20%
—
—
—
—
cases:3.71%
controls:0.84%
cases:11.11%
controls:3.49%
33
147
418
4363
16
53
435
4457
5
9
446
4501
—
—
16
37
415
4369
40
132
320
3651
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1742-6 [3006923]
1742-6 [3006923]
2.6e-01
3.1e-01
7.0e-01
2.9e+00
7.8e-01
3.5e-01
3.4e-01
cases:52.11%
controls:45.61%
cases:43.24%
controls:35.76%
cases:13.53%
controls:7.23%
cases:4.88%
controls:0.29%
cases:14.19%
controls:7.08%
cases:46.87%
controls:38.24%
cases:78.61%
controls:72.40%
235
2057
216
2453
195
1613
256
2897
61
326
390
4184
22
13
429
4497
64
319
387
4189
202
1685
229
2721
283
2739
77
1044
Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
34487-9 [3044938]
34487-9 [3044938]
4.5e-01
1.1e+00
1.3e+00
—
1.9e+00
9.0e-01
8.3e-01
cases:4.43%
controls:2.88%
cases:4.66%
controls:1.64%
cases:1.11%
controls:0.31%
—
—
cases:1.55%
controls:0.24%
cases:4.41%
controls:1.84%
cases:14.17%
controls:6.69%
20
130
431
4380
21
74
430
4436
5
14
446
4496
—
7
11
444
4497
19
81
412
4325
51
253
309
3530
Split skin graft
ZZA00 [2001311610]
ZZA00 [2001311610]
2.2e+00
—
—
—
—
—
2.5e+00
cases:2.66%
controls:0.31%
—
—
—
—
—
—
—
—
—
—
cases:2.50%
controls:0.21%
12
14
439
4496
—
—
—
—
—
9
8
351
3775
General psychiatric examination, not elsewhere classified
Z00.4 [45605094]
Z00.4 [45605094]
9.5e-01
1.5e+00
—
—
—
1.9e+00
1.8e+00
cases:3.77%
controls:1.49%
cases:1.33%
controls:0.31%
—
—
—
—
—
—
cases:3.02%
controls:0.45%
cases:7.78%
controls:1.43%
17
67
434
4443
6
14
445
4496
—
—
—
13
20
418
4386
28
54
332
3729
Lymphocytes/Leukocytes in Blood
26478-8 [3002030]
26478-8 [3002030]
4.0e-01
6.7e-01
1.2e+00
—
1.3e+00
6.6e-01
7.5e-01
cases:19.73%
controls:14.15%
cases:16.85%
controls:9.36%
cases:7.32%
controls:2.28%
—
—
cases:7.10%
controls:2.00%
cases:16.71%
controls:9.37%
cases:37.22%
controls:21.86%
89
638
362
3872
76
422
375
4088
33
103
418
4407
—
32
90
419
4418
72
413
359
3993
134
827
226
2956
Psychological disorders other
P99 [2002000880]
P99 [2002000880]
1.3e+00
2.7e+00
—
—
—
—
1.9e+00
cases:1.77%
controls:0.51%
cases:2.00%
controls:0.13%
—
—
—
—
—
—
—
—
cases:2.22%
controls:0.34%
8
23
443
4487
9
6
442
4504
—
—
—
—
8
13
352
3770
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
X69 [45585661]
X69 [45585661]
2.2e+00
—
—
1.0e+50
—
—
2.4e+00
cases:3.77%
controls:0.42%
—
—
—
—
cases:1.55%
controls:0.00%
—
—
—
—
cases:2.22%
controls:0.21%
17
19
434
4491
—
—
7
0
444
4510
—
—
8
8
352
3775
Physical abuse
T74.1 [45594864]
T74.1 [45594864]
2.3e+00
—
—
—
—
—
2.3e+00
cases:1.33%
controls:0.13%
—
—
—
—
—
—
—
—
—
—
cases:2.22%
controls:0.24%
6
6
445
4504
—
—
—
—
—
8
9
352
3774
pH of Capillary blood
2745-8 [3009343]
2745-8 [3009343]
1.0e+00
1.5e+00
—
—
—
1.1e+00
9.2e-01
cases:3.55%
controls:1.29%
cases:3.33%
controls:0.78%
—
—
—
—
—
—
cases:3.02%
controls:1.00%
cases:6.39%
controls:2.64%
16
58
435
4452
15
35
436
4475
—
—
—
13
44
418
4362
23
100
337
3683
Sepsis due to Staphylococcus aureus
A41.0 [45532832]
A41.0 [45532832]
2.7e+00
—
—
—
—
—
1.8e+00
cases:2.00%
controls:0.13%
—
—
—
—
—
—
—
—
—
—
cases:1.94%
controls:0.32%
9
6
442
4504
—
—
—
—
—
7
12
353
3771
Bacteria [#/volume] in Urine by Automated count
51480-2 [3031040]
51480-2 [3031040]
4.3e-01
7.1e-01
1.3e+00
—
9.5e-01
5.6e-01
5.8e-01
cases:29.71%
controls:21.55%
cases:22.17%
controls:12.26%
cases:6.65%
controls:1.91%
—
—
cases:5.10%
controls:2.04%
cases:19.72%
controls:12.30%
cases:45.83%
controls:32.06%
134
972
317
3538
100
553
351
3957
30
86
421
4424
—
23
92
428
4416
85
542
346
3864
165
1213
195
2570
Urology
34 [38004474]
34 [38004474]
4.6e-01
6.8e-01
1.3e+00
—
1.8e+00
7.2e-01
4.7e-01
cases:11.75%
controls:7.76%
cases:8.20%
controls:4.32%
cases:3.55%
controls:0.98%
—
—
cases:2.88%
controls:0.49%
cases:6.96%
controls:3.52%
cases:14.17%
controls:9.36%
53
350
398
4160
37
195
414
4315
16
44
435
4466
—
13
22
438
4486
30
155
401
4251
51
354
309
3429
Neutrophils/Leukocytes in Blood
26511-6 [3018010]
26511-6 [3018010]
3.8e-01
6.4e-01
1.1e+00
—
1.4e+00
6.1e-01
7.5e-01
cases:19.07%
controls:13.92%
cases:15.74%
controls:8.96%
cases:6.65%
controls:2.22%
—
—
cases:6.65%
controls:1.80%
cases:15.55%
controls:9.06%
cases:36.39%
controls:21.20%
86
628
365
3882
71
404
380
4106
30
100
421
4410
—
30
81
421
4427
67
399
364
4007
131
802
229
2981
Eosinophils [#/volume] in Blood
26449-9 [3013115]
26449-9 [3013115]
2.7e-01
5.9e-01
1.2e+00
—
1.5e+00
5.6e-01
6.3e-01
cases:19.07%
controls:15.30%
cases:16.63%
controls:9.96%
cases:7.54%
controls:2.35%
—
—
cases:8.20%
controls:1.95%
cases:16.47%
controls:10.10%
cases:36.94%
controls:23.84%
86
690
365
3820
75
449
376
4061
34
106
417
4404
—
37
88
414
4420
71
445
360
3961
133
902
227
2881
Chronic ulcer of skin, not elsewhere classified
L98.4 [45533667]
L98.4 [45533667]
2.3e+00
—
—
—
—
—
2.2e+00
cases:1.55%
controls:0.16%
—
—
—
—
—
—
—
—
—
—
cases:2.50%
controls:0.29%
7
7
444
4503
—
—
—
—
—
9
11
351
3772
Monocytes [#/volume] in Blood
26484-6 [3001604]
26484-6 [3001604]
3.2e-01
6.1e-01
1.2e+00
—
1.4e+00
5.8e-01
6.8e-01
cases:18.85%
controls:14.39%
cases:16.41%
controls:9.65%
cases:7.10%
controls:2.26%
—
—
cases:7.32%
controls:1.86%
cases:16.24%
controls:9.78%
cases:37.22%
controls:23.13%
85
649
366
3861
74
435
377
4075
32
102
419
4408
—
33
84
418
4424
70
431
361
3975
134
875
226
2908
Basophils [#/volume] in Blood
26444-0 [3006315]
26444-0 [3006315]
3.3e-01
6.1e-01
1.2e+00
—
1.4e+00
5.7e-01
6.9e-01
cases:19.07%
controls:14.50%
cases:16.41%
controls:9.67%
cases:7.10%
controls:2.26%
—
—
cases:7.32%
controls:1.86%
cases:16.24%
controls:9.85%
cases:37.50%
controls:23.18%
86
654
365
3856
74
436
377
4074
32
102
419
4408
—
33
84
418
4424
70
434
361
3972
135
877
225
2906
FISTULA - Fistula
FISTULA-1 [2002330212]
FISTULA-1 [2002330212]
2.0e+00
—
—
—
—
—
2.5e+00
cases:1.55%
controls:0.22%
—
—
—
—
—
—
—
—
—
—
cases:1.94%
controls:0.16%
7
10
444
4500
—
—
—
—
—
7
6
353
3777
Cathetrisation of vein
TPH04 [2001309597]
TPH04 [2001309597]
8.4e-01
1.3e+00
—
—
—
1.2e+00
1.1e+00
cases:7.32%
controls:3.30%
cases:4.66%
controls:1.31%
—
—
—
—
—
—
cases:5.10%
controls:1.61%
cases:11.67%
controls:4.07%
33
149
418
4361
21
59
430
4451
—
—
—
22
71
409
4335
42
154
318
3629
metronidazole; oral, rectal
P01AB01 [21604857]
P01AB01 [21604857]
7.3e-01
8.3e-01
—
—
2.0e+00
9.5e-01
5.8e-01
cases:15.30%
controls:7.98%
cases:4.88%
controls:2.20%
—
—
—
—
cases:1.55%
controls:0.22%
cases:5.10%
controls:2.04%
cases:11.39%
controls:6.74%
69
360
382
4150
22
99
429
4411
—
—
7
10
444
4498
22
90
409
4316
41
255
319
3528
Chronic kidney disease, unspecified
N18.9 [45553438]
N18.9 [45553438]
1.4e+00
1.8e+00
1.3e+00
—
—
1.3e+00
4.9e-01
cases:3.77%
controls:0.93%
cases:2.88%
controls:0.51%
cases:1.11%
controls:0.31%
—
—
—
—
cases:2.78%
controls:0.79%
cases:2.78%
controls:1.72%
17
42
434
4468
13
23
438
4487
5
14
446
4496
—
—
12
35
419
4371
10
65
350
3718
Decubitus ulcer and pressure area
L89 [45601235]
L89 [45601235]
2.2e+00
—
—
—
—
—
2.2e+00
cases:1.55%
controls:0.18%
—
—
—
—
—
—
—
—
—
—
cases:2.78%
controls:0.32%
7
8
444
4502
—
—
—
—
—
10
12
350
3771
Lymphocytes [#/volume] in Blood
26474-7 [3019198]
26474-7 [3019198]
3.3e-01
6.0e-01
1.2e+00
—
1.4e+00
5.6e-01
6.7e-01
cases:19.96%
controls:15.19%
cases:16.85%
controls:9.98%
cases:7.32%
controls:2.39%
—
—
cases:7.32%
controls:2.00%
cases:16.47%
controls:10.12%
cases:38.06%
controls:23.92%
90
685
361
3825
76
450
375
4060
33
108
418
4402
—
33
90
418
4418
71
446
360
3960
137
905
223
2878
Magnesium [Moles/volume] in Serum or Plasma
2601-3 [3012095]
2601-3 [3012095]
1.1e+00
1.2e+00
1.4e+00
—
1.5e+00
1.2e+00
8.7e-01
cases:9.31%
controls:3.46%
cases:6.87%
controls:2.15%
cases:1.77%
controls:0.44%
—
—
cases:1.55%
controls:0.35%
cases:6.03%
controls:1.88%
cases:12.78%
controls:5.76%
42
156
409
4354
31
97
420
4413
8
20
443
4490
—
7
16
444
4492
26
83
405
4323
46
218
314
3565
Bacteria [#/volume] in Urine by Culture
100906-7 [1761482]
100906-7 [1761482]
1.9e+00
1.3e+00
—
—
—
1.1e+00
1.1e+00
cases:5.32%
controls:0.84%
cases:2.88%
controls:0.78%
—
—
—
—
—
—
cases:2.09%
controls:0.68%
cases:5.00%
controls:1.74%
24
38
427
4472
13
35
438
4475
—
—
—
9
30
422
4376
18
66
342
3717
olanzapine and samidorphan
N05AH53 [955100]
N05AH53 [955100]
2.2e+00
—
—
—
—
—
2.1e+00
cases:1.33%
controls:0.16%
—
—
—
—
—
—
—
—
—
—
cases:2.22%
controls:0.26%
6
7
445
4503
—
—
—
—
—
8
10
352
3773
ibuprofen; oral, parenteral, rectal
M01AE01 [21603967]
M01AE01 [21603967]
2.4e-01
2.1e-01
9.4e-01
2.5e+00
8.8e-01
1.4e-01
1.7e-01
cases:46.34%
controls:40.40%
cases:21.29%
controls:17.94%
cases:5.76%
controls:2.33%
cases:1.55%
controls:0.13%
cases:5.54%
controls:2.37%
cases:19.26%
controls:17.11%
cases:42.22%
controls:38.14%
209
1822
242
2688
96
809
355
3701
26
105
425
4405
7
6
444
4504
25
107
426
4401
83
754
348
3652
152
1443
208
2340
ibuprofen
R02AX02 [1588667]
R02AX02 [1588667]
2.4e-01
2.1e-01
9.4e-01
2.5e+00
8.8e-01
1.4e-01
1.7e-01
cases:46.34%
controls:40.40%
cases:21.29%
controls:17.94%
cases:5.76%
controls:2.33%
cases:1.55%
controls:0.13%
cases:5.54%
controls:2.37%
cases:19.26%
controls:17.11%
cases:42.22%
controls:38.14%
209
1822
242
2688
96
809
355
3701
26
105
425
4405
7
6
444
4504
25
107
426
4401
83
754
348
3652
152
1443
208
2340
Revision of wound of skin of lower limb
QDB05 [2001309969]
QDB05 [2001309969]
2.1e+00
—
—
—
—
—
2.2e+00
cases:1.77%
controls:0.22%
—
—
—
—
—
—
—
—
—
—
cases:2.78%
controls:0.32%
8
10
443
4500
—
—
—
—
—
10
12
350
3771
Vacuum treatment of wound
TQW11 [2001310078]
TQW11 [2001310078]
2.2e+00
—
—
—
—
—
2.1e+00
cases:1.55%
controls:0.18%
—
—
—
—
—
—
—
—
—
—
cases:2.50%
controls:0.32%
7
8
444
4502
—
—
—
—
—
9
12
351
3771
Cardiology
6 [38004451]
6 [38004451]
5.1e-01
6.4e-01
1.3e+00
—
1.1e+00
6.4e-01
4.5e-01
cases:19.07%
controls:12.44%
cases:12.42%
controls:6.96%
cases:4.21%
controls:1.13%
—
—
cases:3.10%
controls:1.04%
cases:11.14%
controls:6.17%
cases:21.67%
controls:15.04%
86
561
365
3949
56
314
395
4196
19
51
432
4459
—
14
47
437
4461
48
272
383
4134
78
569
282
3214
Counselling/guidance promoting independent living
SPAT1222 [2001700323]
SPAT1222 [2001700323]
9.7e-01
9.6e-01
1.4e+00
—
1.0e+00
1.4e+00
8.4e-01
cases:7.32%
controls:2.90%
cases:4.43%
controls:1.75%
cases:1.77%
controls:0.47%
—
—
cases:1.77%
controls:0.64%
cases:4.87%
controls:1.29%
cases:7.50%
controls:3.38%
33
131
418
4379
20
79
431
4431
8
21
443
4489
—
8
29
443
4479
21
57
410
4349
27
128
333
3655
Telehealth
OMOP5556618 [722455]
OMOP5556618 [722455]
3.2e-01
6.2e-01
1.1e+00
—
9.9e-01
7.1e-01
6.6e-01
cases:47.01%
controls:39.14%
cases:27.72%
controls:17.16%
cases:8.20%
controls:2.79%
—
—
cases:6.87%
controls:2.66%
cases:25.99%
controls:14.73%
cases:38.89%
controls:24.77%
212
1765
239
2745
125
774
326
3736
37
126
414
4384
—
31
120
420
4388
112
649
319
3757
140
937
220
2846
Initiation, adjustment, discontinuation or repetition of medication
SPAT1253 [2001700354]
SPAT1253 [2001700354]
7.5e-01
7.3e-01
1.1e+00
—
1.1e+00
9.0e-01
6.1e-01
cases:18.85%
controls:9.89%
cases:8.20%
controls:4.15%
cases:2.88%
controls:0.98%
—
—
cases:2.44%
controls:0.80%
cases:7.42%
controls:3.15%
cases:14.17%
controls:8.25%
85
446
366
4064
37
187
414
4323
13
44
438
4466
—
11
36
440
4472
32
139
399
4267
51
312
309
3471
EKG study
11524-6 [3013512]
11524-6 [3013512]
6.7e-01
8.4e-01
1.1e+00
1.0e+50
1.2e+00
8.4e-01
4.9e-01
cases:17.96%
controls:10.07%
cases:12.86%
controls:5.96%
cases:2.00%
controls:0.64%
cases:2.66%
controls:0.00%
cases:2.66%
controls:0.80%
cases:13.23%
controls:6.15%
cases:23.89%
controls:16.18%
81
454
370
4056
58
269
393
4241
9
29
442
4481
12
0
439
4510
12
36
439
4472
57
271
374
4135
86
612
274
3171
Neutrophils [#/volume] in Blood by Automated count
751-8 [3013650]
751-8 [3013650]
2.3e-01
5.4e-01
1.1e+00
—
1.1e+00
6.1e-01
6.2e-01
cases:20.84%
controls:17.36%
cases:18.85%
controls:11.93%
cases:9.76%
controls:3.41%
—
—
cases:8.65%
controls:2.95%
cases:20.42%
controls:12.23%
cases:39.72%
controls:26.12%
94
783
357
3727
85
538
366
3972
44
154
407
4356
—
39
133
412
4375
88
539
343
3867
143
988
217
2795
Assessment of need for aid
SPAT1229 [2001700330]
SPAT1229 [2001700330]
1.2e+00
1.6e+00
—
—
—
1.4e+00
1.2e+00
cases:3.55%
controls:1.09%
cases:2.22%
controls:0.44%
—
—
—
—
—
—
cases:2.09%
controls:0.50%
cases:3.61%
controls:1.14%
16
49
435
4461
10
20
441
4490
—
—
—
9
22
422
4384
13
43
347
3740
Epithelial cells [#/volume] in Urine
30383-4 [3000850]
30383-4 [3000850]
3.2e-01
7.8e-01
1.5e+00
—
7.7e-01
9.9e-01
7.8e-01
cases:8.20%
controls:6.12%
cases:6.21%
controls:2.95%
cases:2.00%
controls:0.47%
—
—
cases:1.33%
controls:0.62%
cases:6.03%
controls:2.34%
cases:15.83%
controls:7.96%
37
276
414
4234
28
133
423
4377
9
21
442
4489
—
6
28
445
4480
26
103
405
4303
57
301
303
3482
Pneumonia, unspecified
J18.9 [45601123]
J18.9 [45601123]
7.1e-01
1.1e+00
—
—
—
1.2e+00
9.6e-01
cases:7.98%
controls:4.10%
cases:4.43%
controls:1.51%
—
—
—
—
—
—
cases:4.87%
controls:1.50%
cases:12.22%
controls:5.08%
36
185
415
4325
20
68
431
4442
—
—
—
21
66
410
4340
44
192
316
3591
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
Y83 [45552036]
Y83 [45552036]
2.0e+00
—
—
—
—
—
2.0e+00
cases:3.33%
controls:0.47%
—
—
—
—
—
—
—
—
—
—
cases:2.78%
controls:0.40%
15
21
436
4489
—
—
—
—
—
10
15
350
3768
Sepsis, unspecified
A41.9 [45585911]
A41.9 [45585911]
2.1e+00
—
—
—
—
—
1.8e+00
cases:2.22%
controls:0.27%
—
—
—
—
—
—
—
—
—
—
cases:2.22%
controls:0.37%
10
12
441
4498
—
—
—
—
—
8
14
352
3769
Treatment of a patient needing special arrangements
WYA30 [2001310874]
WYA30 [2001310874]
9.3e-01
9.9e-01
—
—
—
1.4e+00
1.6e+00
cases:4.21%
controls:1.71%
cases:1.77%
controls:0.67%
—
—
—
—
—
—
cases:2.55%
controls:0.66%
cases:6.94%
controls:1.43%
19
77
432
4433
8
30
443
4480
—
—
—
11
29
420
4377
25
54
335
3729
perphenazine; oral, parenteral, rectal
N05AB03 [21604502]
N05AB03 [21604502]
1.8e+00
2.2e+00
—
—
—
2.0e+00
1.9e+00
cases:1.55%
controls:0.27%
cases:1.33%
controls:0.16%
—
—
—
—
—
—
cases:1.16%
controls:0.16%
cases:1.39%
controls:0.21%
7
12
444
4498
6
7
445
4503
—
—
—
5
7
426
4399
5
8
355
3775
Ophthalmology
18 [38004463]
18 [38004463]
4.0e-01
4.6e-01
2.8e-01
2.5e+00
4.3e-01
5.4e-01
4.7e-01
cases:23.73%
controls:17.29%
cases:11.53%
controls:7.61%
cases:2.22%
controls:1.69%
cases:1.33%
controls:0.11%
cases:2.44%
controls:1.60%
cases:13.46%
controls:8.28%
cases:28.89%
controls:20.17%
107
780
344
3730
52
343
399
4167
10
76
441
4434
6
5
445
4505
11
72
440
4436
58
365
373
4041
104
763
256
3020
Functional capacity evaluation
443351003 [40481051]
443351003 [40481051]
7.9e-01
1.1e+00
1.4e+00
—
—
1.1e+00
9.8e-01
cases:5.99%
controls:2.82%
cases:3.55%
controls:1.26%
cases:1.11%
controls:0.27%
—
—
—
—
cases:4.41%
controls:1.54%
cases:8.61%
controls:3.41%
27
127
424
4383
16
57
435
4453
5
12
446
4498
—
—
19
68
412
4338
31
129
329
3654
Leukocyte esterase [Presence] in Urine by Automated test strip
60026-2 [40763086]
60026-2 [40763086]
4.6e-01
7.8e-01
9.8e-01
—
1.5e+00
5.7e-01
5.0e-01
cases:17.74%
controls:11.95%
cases:13.53%
controls:6.67%
cases:2.66%
controls:1.02%
—
—
cases:3.99%
controls:0.91%
cases:11.83%
controls:7.08%
cases:28.33%
controls:19.27%
80
539
371
3971
61
301
390
4209
12
46
439
4464
—
18
41
433
4467
51
312
380
4094
102
729
258
3054
Pain general/multiple sites
A01 [2002000142]
A01 [2002000142]
1.2e+00
—
—
—
—
1.5e+00
1.2e+00
cases:3.77%
controls:1.18%
—
—
—
—
—
—
—
—
cases:2.32%
controls:0.54%
cases:6.94%
controls:2.27%
17
53
434
4457
—
—
—
—
10
24
421
4382
25
86
335
3697
lactulose; oral
A06AD11 [21600571]
A06AD11 [21600571]
8.2e-01
1.3e+00
—
—
—
1.1e+00
1.4e+00
cases:4.66%
controls:2.11%
cases:3.55%
controls:0.95%
—
—
—
—
—
—
cases:3.71%
controls:1.25%
cases:8.89%
controls:2.43%
21
95
430
4415
16
43
435
4467
—
—
—
16
55
415
4351
32
92
328
3691
cetirizine; oral
R06AE07 [21603497]
R06AE07 [21603497]
1.7e-01
6.9e-01
1.2e+00
—
1.6e+00
7.7e-01
7.7e-01
cases:9.53%
controls:8.16%
cases:8.20%
controls:4.28%
cases:2.22%
controls:0.67%
—
—
cases:3.10%
controls:0.67%
cases:8.82%
controls:4.27%
cases:16.11%
controls:8.14%
43
368
408
4142
37
193
414
4317
10
30
441
4480
—
14
30
437
4478
38
188
393
4218
58
308
302
3475
Anion gap in Blood by calculation
41276-7 [3039000]
41276-7 [3039000]
—
1.8e+00
—
—
—
2.3e+00
1.4e+00
—
—
cases:1.33%
controls:0.22%
—
—
—
—
—
—
cases:1.62%
controls:0.16%
cases:3.06%
controls:0.74%
—
6
10
445
4500
—
—
—
7
7
424
4399
11
28
349
3755
Chloride [Moles/volume] in Blood
2069-3 [3018572]
2069-3 [3018572]
—
1.8e+00
—
—
—
2.3e+00
1.4e+00
—
—
cases:1.33%
controls:0.22%
—
—
—
—
—
—
cases:1.62%
controls:0.16%
cases:3.06%
controls:0.74%
—
6
10
445
4500
—
—
—
7
7
424
4399
11
28
349
3755
Bacteria identified in Isolate by Culture
43409-2 [3042936]
43409-2 [3042936]
1.1e+00
8.9e-01
1.5e+00
1.0e+50
—
1.6e+00
1.1e+00
cases:8.20%
controls:3.02%
cases:3.99%
controls:1.69%
cases:1.33%
controls:0.31%
cases:1.33%
controls:0.00%
—
—
cases:7.66%
controls:1.70%
cases:11.94%
controls:4.20%
37
136
414
4374
18
76
433
4434
6
14
445
4496
6
0
445
4510
—
33
75
398
4331
43
159
317
3624
fusidic acid
D09AA02 [21602265]
D09AA02 [21602265]
6.2e-01
1.1e+00
2.7e+00
—
—
7.0e-01
5.6e-01
cases:7.54%
controls:4.21%
cases:4.43%
controls:1.53%
cases:1.55%
controls:0.11%
—
—
—
—
cases:2.78%
controls:1.41%
cases:8.89%
controls:5.29%
34
190
417
4320
20
69
431
4441
7
5
444
4505
—
—
12
62
419
4344
32
200
328
3583
fusidic acid; ointment
D06AX01 [21602062]
D06AX01 [21602062]
6.2e-01
1.1e+00
2.7e+00
—
—
7.0e-01
5.6e-01
cases:7.54%
controls:4.21%
cases:4.43%
controls:1.53%
cases:1.55%
controls:0.11%
—
—
—
—
cases:2.78%
controls:1.41%
cases:8.89%
controls:5.29%
34
190
417
4320
20
69
431
4441
7
5
444
4505
—
—
12
62
419
4344
32
200
328
3583
Bipolar affective disorder, unspecified
F31.9 [45571758]
F31.9 [45571758]
8.7e-01
—
—
—
—
2.0e+00
1.7e+00
cases:1.11%
controls:0.47%
—
—
—
—
—
—
—
—
cases:1.39%
controls:0.18%
cases:2.50%
controls:0.48%
5
21
446
4489
—
—
—
—
6
8
425
4398
9
18
351
3765
Treatment of reopened or infected surgical wound
SPAT1144 [2001700245]
SPAT1144 [2001700245]
1.4e+00
—
—
—
—
2.3e+00
1.2e+00
cases:3.99%
controls:1.04%
—
—
—
—
—
—
—
—
cases:2.55%
controls:0.25%
cases:3.33%
controls:1.03%
18
47
433
4463
—
—
—
—
11
11
420
4395
12
39
348
3744
Other diagnostic examination of periferal vessel
XPX99 [2001309755]
XPX99 [2001309755]
5.4e-01
1.4e+00
—
—
—
1.9e+00
1.8e+00
cases:1.77%
controls:1.04%
cases:1.11%
controls:0.29%
—
—
—
—
—
—
cases:1.86%
controls:0.27%
cases:4.17%
controls:0.74%
8
47
443
4463
5
13
446
4497
—
—
—
8
12
423
4394
15
28
345
3755
propranolol; oral, parenteral
C07AA05 [21601670]
C07AA05 [21601670]
8.4e-01
1.0e+00
8.7e-01
—
1.3e+00
1.1e+00
6.8e-01
cases:10.64%
controls:4.90%
cases:6.43%
controls:2.39%
cases:1.11%
controls:0.47%
—
—
cases:1.33%
controls:0.35%
cases:6.50%
controls:2.18%
cases:10.56%
controls:5.66%
48
221
403
4289
29
108
422
4402
5
21
446
4489
—
6
16
445
4492
28
96
403
4310
38
214
322
3569
Erythrocytes [#/volume] in Urine
30391-7 [3002582]
30391-7 [3002582]
3.6e-01
8.2e-01
1.3e+00
—
9.3e-01
8.8e-01
7.1e-01
cases:11.09%
controls:8.03%
cases:9.76%
controls:4.55%
cases:2.66%
controls:0.78%
—
—
cases:2.22%
controls:0.89%
cases:10.67%
controls:4.72%
cases:26.94%
controls:15.36%
50
362
401
4148
44
205
407
4305
12
35
439
4475
—
10
40
441
4468
46
208
385
4198
97
581
263
3202
levofloxacin; inhalant, oral, parenteral
J01MA12 [21603019]
J01MA12 [21603019]
8.0e-01
6.2e-01
—
—
2.1e+00
1.7e+00
1.1e+00
cases:5.76%
controls:2.68%
cases:1.55%
controls:0.84%
—
—
—
—
cases:1.11%
controls:0.13%
cases:3.48%
controls:0.64%
cases:6.94%
controls:2.43%
26
121
425
4389
7
38
444
4472
—
—
5
6
446
4502
15
28
416
4378
25
92
335
3691
Simple examination of mouth
SAA01 [2001310274]
SAA01 [2001310274]
4.8e-01
3.8e-01
8.4e-01
—
1.1e+00
6.4e-01
5.2e-01
cases:42.57%
controls:31.49%
cases:21.06%
controls:15.39%
cases:4.66%
controls:2.06%
—
—
cases:5.54%
controls:1.89%
cases:24.83%
controls:14.80%
cases:49.17%
controls:36.40%
192
1420
259
3090
95
694
356
3816
21
93
430
4417
—
25
85
426
4423
107
652
324
3754
177
1377
183
2406
Headache
R51.80 [2000503603]
R51.80 [2000503603]
8.6e-01
1.4e+00
—
—
—
1.2e+00
1.3e+00
cases:4.88%
controls:2.13%
cases:3.10%
controls:0.80%
—
—
—
—
—
—
cases:2.32%
controls:0.68%
cases:8.89%
controls:2.67%
22
96
429
4414
14
36
437
4474
—
—
—
10
30
421
4376
32
101
328
3682
Lactate [Moles/volume] in Blood
32693-4 [3047181]
32693-4 [3047181]
7.4e-01
1.5e+00
—
—
—
2.1e+00
1.4e+00
cases:1.11%
controls:0.53%
cases:1.55%
controls:0.35%
—
—
—
—
—
—
cases:2.32%
controls:0.30%
cases:4.72%
controls:1.19%
5
24
446
4486
7
16
444
4494
—
—
—
10
13
421
4393
17
45
343
3738
Ammonium ion [Moles/volume] in Plasma
1845-7 [3023183]
1845-7 [3023183]
1.2e+00
1.9e+00
—
—
—
1.9e+00
1.6e+00
cases:1.55%
controls:0.49%
cases:1.55%
controls:0.24%
—
—
—
—
—
—
cases:1.39%
controls:0.20%
cases:3.89%
controls:0.79%
7
22
444
4488
7
11
444
4499
—
—
—
6
9
425
4397
14
30
346
3753
Kidney transplant status
Z94.0 [45566477]
Z94.0 [45566477]
1.7e+00
1.5e+00
—
—
1.7e+00
1.4e+00
1.8e+00
cases:1.77%
controls:0.33%
cases:1.77%
controls:0.40%
—
—
—
—
cases:1.11%
controls:0.20%
cases:1.62%
controls:0.39%
cases:2.78%
controls:0.48%
8
15
443
4495
8
18
443
4492
—
—
5
9
446
4499
7
17
424
4389
10
18
350
3765
Carbon dioxide [Partial pressure] in Blood
11557-6 [3013290]
11557-6 [3013290]
8.7e-01
1.4e+00
—
—
—
2.0e+00
1.5e+00
cases:1.11%
controls:0.47%
cases:1.11%
controls:0.27%
—
—
—
—
—
—
cases:2.09%
controls:0.30%
cases:2.78%
controls:0.63%
5
21
446
4489
5
12
446
4498
—
—
—
9
13
422
4393
10
24
350
3759
Base excess in Blood by calculation
11555-0 [3012501]
11555-0 [3012501]
8.7e-01
1.4e+00
—
—
—
2.0e+00
1.5e+00
cases:1.11%
controls:0.47%
cases:1.11%
controls:0.27%
—
—
—
—
—
—
cases:2.09%
controls:0.30%
cases:2.78%
controls:0.63%
5
21
446
4489
5
12
446
4498
—
—
—
9
13
422
4393
10
24
350
3759
Oxygen [Partial pressure] in Blood
11556-8 [3027315]
11556-8 [3027315]
9.2e-01
1.4e+00
—
—
—
2.0e+00
1.5e+00
cases:1.11%
controls:0.44%
cases:1.11%
controls:0.27%
—
—
—
—
—
—
cases:2.09%
controls:0.30%
cases:2.78%
controls:0.63%
5
20
446
4490
5
12
446
4498
—
—
—
9
13
422
4393
10
24
350
3759
Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method
4537-7 [3013707]
4537-7 [3013707]
3.4e-01
5.2e-01
1.1e+00
—
1.0e+00
4.6e-01
4.2e-01
cases:31.93%
controls:25.08%
cases:21.51%
controls:14.04%
cases:5.54%
controls:2.00%
—
—
cases:5.54%
controls:2.09%
cases:20.65%
controls:14.16%
cases:46.67%
controls:36.43%
144
1131
307
3379
97
633
354
3877
25
90
426
4420
—
25
94
426
4414
89
624
342
3782
168
1378
192
2405
Leukocytes [#/volume] in Urine
30405-5 [3018095]
30405-5 [3018095]
2.5e-01
7.6e-01
1.2e+00
—
9.8e-01
7.8e-01
6.8e-01
cases:11.09%
controls:8.89%
cases:10.64%
controls:5.25%
cases:2.88%
controls:0.89%
—
—
cases:2.44%
controls:0.93%
cases:11.14%
controls:5.42%
cases:29.72%
controls:17.61%
50
401
401
4109
48
237
403
4273
13
40
438
4470
—
11
42
440
4466
48
239
383
4167
107
666
253
3117
Intraoral radiographic dental examination
EB1AA [2001301903]
EB1AA [2001301903]
3.5e-01
6.9e-01
1.3e+00
—
5.7e-01
8.2e-01
6.4e-01
cases:26.39%
controls:20.13%
cases:12.86%
controls:6.92%
cases:2.66%
controls:0.75%
—
—
cases:1.33%
controls:0.75%
cases:14.39%
controls:6.88%
cases:31.39%
controls:19.46%
119
908
332
3602
58
312
393
4198
12
34
439
4476
—
6
34
445
4474
62
303
369
4103
113
736
247
3047
Carbon dioxide [Partial pressure] in Capillary blood
2020-6 [3023024]
2020-6 [3023024]
1.1e+00
1.5e+00
—
—
—
1.1e+00
8.6e-01
cases:3.55%
controls:1.26%
cases:3.33%
controls:0.78%
—
—
—
—
—
—
cases:3.02%
controls:1.07%
cases:6.39%
controls:2.80%
16
57
435
4453
15
35
436
4475
—
—
—
13
47
418
4359
23
106
337
3677
Bacterial pneumonia, unspecified
J15.9 [45557621]
J15.9 [45557621]
1.1e+00
1.4e+00
—
—
—
1.9e+00
1.4e+00
cases:2.22%
controls:0.75%
cases:1.11%
controls:0.29%
—
—
—
—
—
—
cases:1.86%
controls:0.27%
cases:3.89%
controls:0.95%
10
34
441
4476
5
13
446
4497
—
—
—
8
12
423
4394
14
36
346
3747
Snapping jaw
K07.60 [2000502791]
K07.60 [2000502791]
7.5e-01
—
—
—
—
2.2e+00
1.2e+00
cases:1.77%
controls:0.84%
—
—
—
—
—
—
—
—
cases:1.39%
controls:0.16%
cases:3.61%
controls:1.14%
8
38
443
4472
—
—
—
—
6
7
425
4399
13
43
347
3740
Dietary counselling and surveillance
Z71.3 [45552101]
Z71.3 [45552101]
1.5e+00
1.4e+00
—
—
—
1.8e+00
1.3e+00
cases:3.33%
controls:0.75%
cases:1.55%
controls:0.38%
—
—
—
—
—
—
cases:2.09%
controls:0.34%
cases:2.50%
controls:0.66%
15
34
436
4476
7
17
444
4493
—
—
—
9
15
422
4391
9
25
351
3758
Methemoglobin/Hemoglobin.total in Venous blood
2617-9 [3024889]
2617-9 [3024889]
1.9e+00
1.4e+00
—
—
—
1.4e+00
4.9e-01
cases:3.99%
controls:0.60%
cases:2.22%
controls:0.55%
—
—
—
—
—
—
cases:2.09%
controls:0.50%
cases:4.17%
controls:2.59%
18
27
433
4483
10
25
441
4485
—
—
—
9
22
422
4384
15
98
345
3685
Anesthesiology Critical Care Medicine
OMOP4821991 [45756751]
OMOP4821991 [45756751]
1.3e+00
1.4e+00
—
—
—
2.1e+00
1.3e+00
cases:3.77%
controls:1.11%
cases:1.55%
controls:0.38%
—
—
—
—
—
—
cases:3.02%
controls:0.39%
cases:3.06%
controls:0.87%
17
50
434
4460
7
17
444
4493
—
—
—
13
17
418
4389
11
33
349
3750
calcium (different salts in combination); oral
A12AA20 [21600872]
A12AA20 [21600872]
5.7e-01
5.5e-01
4.5e-01
-1.0e+50
9.4e-01
5.5e-01
7.1e-01
cases:16.85%
controls:10.24%
cases:13.53%
controls:8.29%
cases:3.33%
controls:2.15%
cases:0.00%
controls:0.11%
cases:5.10%
controls:2.06%
cases:14.15%
controls:8.67%
cases:20.83%
controls:11.45%
76
462
375
4048
61
374
390
4136
15
97
436
4413
0
5
451
4505
23
93
428
4415
61
382
370
4024
75
433
285
3350
Carboxyhemoglobin/Hemoglobin.total in Venous blood
2032-1 [3010517]
2032-1 [3010517]
1.9e+00
1.4e+00
—
—
—
1.4e+00
5.2e-01
cases:3.99%
controls:0.62%
cases:2.22%
controls:0.55%
—
—
—
—
—
—
cases:2.09%
controls:0.52%
cases:4.44%
controls:2.70%
18
28
433
4482
10
25
441
4485
—
—
—
9
23
422
4383
16
102
344
3681
Reticulocytes/Erythrocytes in Blood
4679-7 [3027945]
4679-7 [3027945]
7.6e-01
9.7e-01
2.3e+00
—
—
7.1e-01
5.0e-01
cases:5.32%
controls:2.57%
cases:3.55%
controls:1.37%
cases:1.55%
controls:0.16%
—
—
—
—
cases:2.78%
controls:1.38%
cases:8.06%
controls:5.02%
24
116
427
4394
16
62
435
4448
7
7
444
4503
—
—
12
61
419
4345
29
190
331
3593
Persistent somatoform pain disorder
F45.4 [45605498]
F45.4 [45605498]
—
—
—
—
—
—
3.3e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:3.33%
controls:0.13%
—
—
—
—
—
—
12
5
348
3778
amoxicillin and beta-lactamase inhibitor; oral, parenteral
J01CR02 [21602863]
J01CR02 [21602863]
2.3e-01
6.2e-01
—
—
1.9e+00
7.7e-01
6.0e-01
cases:12.86%
controls:10.53%
cases:5.32%
controls:2.95%
—
—
—
—
cases:1.55%
controls:0.24%
cases:6.26%
controls:3.00%
cases:15.00%
controls:8.83%
58
475
393
4035
24
133
427
4377
—
—
7
11
444
4497
27
132
404
4274
54
334
306
3449
Neurology
13 [38004458]
13 [38004458]
4.9e-01
1.0e+00
1.2e+00
—
1.1e+00
9.8e-01
7.2e-01
cases:17.74%
controls:11.66%
cases:12.86%
controls:4.92%
cases:2.44%
controls:0.75%
—
—
cases:2.88%
controls:1.02%
cases:12.30%
controls:4.99%
cases:22.78%
controls:12.61%
80
526
371
3984
58
222
393
4288
11
34
440
4476
—
13
46
438
4462
53
220
378
4186
82
477
278
3306
Bicarbonate [Moles/volume] in Arterial blood
1960-4 [3008152]
1960-4 [3008152]
7.6e-01
1.5e+00
—
—
—
1.8e+00
7.9e-01
cases:2.66%
controls:1.26%
cases:3.10%
controls:0.73%
—
—
—
—
—
—
cases:3.94%
controls:0.70%
cases:5.00%
controls:2.33%
12
57
439
4453
14
33
437
4477
—
—
—
17
31
414
4375
18
88
342
3695
ferrous glycine sulfate; oral
B03AA01 [21601080]
B03AA01 [21601080]
1.0e+00
1.3e+00
-1.0e+50
—
—
1.9e+00
1.4e+00
cases:2.88%
controls:1.04%
cases:1.77%
controls:0.49%
cases:0.00%
controls:0.22%
—
—
—
—
cases:2.55%
controls:0.41%
cases:6.11%
controls:1.64%
13
47
438
4463
8
22
443
4488
0
10
451
4500
—
—
11
18
420
4388
22
62
338
3721
Chest pain, unspecified
R07.4 [45558450]
R07.4 [45558450]
3.4e-01
6.1e-01
1.6e+00
—
—
9.4e-01
6.4e-01
cases:7.98%
controls:5.83%
cases:3.33%
controls:1.84%
cases:1.77%
controls:0.35%
—
—
—
—
cases:4.18%
controls:1.68%
cases:11.11%
controls:6.19%
36
263
415
4247
15
83
436
4427
8
16
443
4494
—
—
18
74
413
4332
40
234
320
3549
Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
2157-6 [3007220]
2157-6 [3007220]
4.5e-01
1.1e+00
1.2e+00
—
1.5e+00
5.3e-01
6.4e-01
cases:11.53%
controls:7.65%
cases:9.76%
controls:3.61%
cases:1.33%
controls:0.40%
—
—
cases:2.44%
controls:0.55%
cases:6.26%
controls:3.77%
cases:21.39%
controls:12.58%
52
345
399
4165
44
163
407
4347
6
18
445
4492
—
11
25
440
4483
27
166
404
4240
77
476
283
3307
Chloride [Moles/volume] in Serum or Plasma
2075-0 [3014576]
2075-0 [3014576]
5.6e-01
1.1e+00
1.4e+00
—
—
1.2e+00
8.4e-01
cases:3.99%
controls:2.33%
cases:3.99%
controls:1.31%
cases:1.33%
controls:0.33%
—
—
—
—
cases:3.94%
controls:1.20%
cases:11.94%
controls:5.55%
18
105
433
4405
18
59
433
4451
6
15
445
4495
—
—
17
53
414
4353
43
210
317
3573
Pain in limb
M79.6 [45587063]
M79.6 [45587063]
6.3e-01
8.0e-01
1.2e+00
—
—
1.1e+00
6.1e-01
cases:12.42%
controls:7.05%
cases:6.65%
controls:3.10%
cases:1.11%
controls:0.33%
—
—
—
—
cases:8.58%
controls:2.93%
cases:23.33%
controls:14.22%
56
318
395
4192
30
140
421
4370
5
15
446
4495
—
—
37
129
394
4277
84
538
276
3245
Other specified special examinations
Z01.8 [45581003]
Z01.8 [45581003]
9.2e-01
1.0e+00
—
—
—
1.2e+00
1.1e+00
cases:7.32%
controls:3.04%
cases:2.66%
controls:0.98%
—
—
—
—
—
—
cases:3.71%
controls:1.18%
cases:11.11%
controls:4.12%
33
137
418
4373
12
44
439
4466
—
—
—
16
52
415
4354
40
156
320
3627
pantoprazole; oral, parenteral
A02BC02 [21600097]
A02BC02 [21600097]
3.9e-01
5.8e-01
5.7e-01
—
9.8e-01
6.7e-01
5.4e-01
cases:29.71%
controls:22.20%
cases:19.96%
controls:12.24%
cases:4.66%
controls:2.68%
—
—
cases:6.87%
controls:2.71%
cases:22.27%
controls:12.80%
cases:37.22%
controls:25.61%
134
1001
317
3509
90
552
361
3958
21
121
430
4389
—
31
122
420
4386
96
564
335
3842
134
969
226
2814
Administration of medicine
SPAT1254 [2001700355]
SPAT1254 [2001700355]
7.1e-01
5.8e-01
1.2e+00
—
1.4e+00
1.4e+00
1.1e+00
cases:6.65%
controls:3.39%
cases:2.66%
controls:1.51%
cases:1.55%
controls:0.49%
—
—
cases:2.00%
controls:0.49%
cases:5.10%
controls:1.32%
cases:8.33%
controls:3.07%
30
153
421
4357
12
68
439
4442
7
22
444
4488
—
9
22
442
4486
22
58
409
4348
30
116
330
3667
Infiltration anesthesia
WX110 [2001310767]
WX110 [2001310767]
3.8e-01
3.9e-01
5.6e-01
1.0e+50
1.2e+00
8.2e-01
7.9e-01
cases:36.59%
controls:28.31%
cases:15.74%
controls:11.24%
cases:2.66%
controls:1.53%
cases:4.43%
controls:0.00%
cases:3.99%
controls:1.29%
cases:20.88%
controls:10.39%
cases:48.33%
controls:29.76%
165
1277
286
3233
71
507
380
4003
12
69
439
4441
20
0
431
4510
18
58
433
4450
90
458
341
3948
174
1126
186
2657
Intravenous administration of medicine
SPAT1255 [2001700356]
SPAT1255 [2001700356]
9.5e-01
1.9e+00
—
—
—
1.2e+00
1.2e+00
cases:2.44%
controls:0.95%
cases:2.22%
controls:0.33%
—
—
—
—
—
—
cases:1.62%
controls:0.48%
cases:3.89%
controls:1.16%
11
43
440
4467
10
15
441
4495
—
—
—
7
21
424
4385
14
44
346
3739
Teaching
WZC30 [2001310891]
WZC30 [2001310891]
8.6e-01
3.8e-01
—
—
—
1.3e+00
9.6e-01
cases:4.43%
controls:1.93%
cases:1.33%
controls:0.91%
—
—
—
—
—
—
cases:3.48%
controls:0.95%
cases:8.89%
controls:3.60%
20
87
431
4423
6
41
445
4469
—
—
—
15
42
416
4364
32
136
328
3647
Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
40987-0 [3043924]
40987-0 [3043924]
2.6e-01
1.2e+00
1.6e+00
—
—
1.2e+00
7.1e-01
cases:2.66%
controls:2.06%
cases:3.55%
controls:1.09%
cases:1.11%
controls:0.22%
—
—
—
—
cases:3.71%
controls:1.13%
cases:10.00%
controls:5.18%
12
93
439
4417
16
49
435
4461
5
10
446
4500
—
—
16
50
415
4356
36
196
324
3587
Depressive disorder
P76 [2002000870]
P76 [2002000870]
8.2e-01
1.8e+00
—
—
—
1.4e+00
1.3e+00
cases:2.44%
controls:1.09%
cases:2.22%
controls:0.38%
—
—
—
—
—
—
cases:1.86%
controls:0.48%
cases:5.28%
controls:1.45%
11
49
440
4461
10
17
441
4493
—
—
—
8
21
423
4385
19
55
341
3728
Otolaryngology
4 [38004449]
4 [38004449]
4.7e-01
6.8e-01
1.4e+00
—
1.1e+00
4.2e-01
5.2e-01
cases:18.40%
controls:12.31%
cases:7.76%
controls:4.10%
cases:2.22%
controls:0.53%
—
—
cases:1.77%
controls:0.58%
cases:6.03%
controls:4.06%
cases:18.33%
controls:11.79%
83
555
368
3955
35
185
416
4325
10
24
441
4486
—
8
26
443
4482
26
179
405
4227
66
446
294
3337
alfacalcidol; oral, parenteral
A11CC03 [21600818]
A11CC03 [21600818]
1.3e+00
1.6e+00
—
—
—
1.2e+00
1.5e+00
cases:2.00%
controls:0.53%
cases:2.00%
controls:0.42%
—
—
—
—
—
—
cases:1.16%
controls:0.36%
cases:2.78%
controls:0.61%
9
24
442
4486
9
19
442
4491
—
—
—
5
16
426
4390
10
23
350
3760
Amylase [Enzymatic activity/volume] in Serum or Plasma
1798-8 [3016771]
1798-8 [3016771]
4.6e-01
1.1e+00
9.3e-01
—
1.3e+00
1.1e+00
9.4e-01
cases:12.64%
controls:8.40%
cases:10.64%
controls:3.95%
cases:1.55%
controls:0.62%
—
—
cases:2.22%
controls:0.62%
cases:10.44%
controls:3.77%
cases:28.61%
controls:13.48%
57
379
394
4131
48
178
403
4332
7
28
444
4482
—
10
28
441
4480
45
166
386
4240
103
510
257
3273
furosemide; oral, parenteral
C03CA01 [21601518]
C03CA01 [21601518]
8.5e-01
6.5e-01
6.2e-01
-1.0e+50
6.7e-01
7.1e-01
8.8e-01
cases:14.63%
controls:6.81%
cases:10.86%
controls:5.99%
cases:3.33%
controls:1.82%
cases:0.00%
controls:0.16%
cases:3.77%
controls:1.97%
cases:12.30%
controls:6.47%
cases:20.00%
controls:9.44%
66
307
385
4203
49
270
402
4240
15
82
436
4428
0
7
451
4503
17
89
434
4419
53
285
378
4121
72
357
288
3426
Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1920-8 [3013721]
1920-8 [3013721]
5.6e-01
8.0e-01
9.3e-01
—
9.8e-01
9.1e-01
7.8e-01
cases:15.30%
controls:9.31%
cases:10.42%
controls:4.97%
cases:2.00%
controls:0.80%
—
—
cases:2.66%
controls:1.02%
cases:10.21%
controls:4.38%
cases:27.22%
controls:14.67%
69
420
382
4090
47
224
404
4286
9
36
442
4474
—
12
46
439
4462
44
193
387
4213
98
555
262
3228
Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
546-2 [3024135]
546-2 [3024135]
4.9e-01
-2.5e-01
2.5e+00
—
—
4.8e-02
5.9e-01
cases:8.65%
controls:5.48%
cases:1.77%
controls:2.26%
cases:1.77%
controls:0.16%
—
—
—
—
cases:1.86%
controls:1.77%
cases:12.78%
controls:7.48%
39
247
412
4263
8
102
443
4408
8
7
443
4503
—
—
8
78
423
4328
46
283
314
3500
Protein [Presence] in Urine by Test strip
20454-5 [3014051]
20454-5 [3014051]
4.8e-01
7.2e-01
1.0e+00
—
2.3e+00
2.5e-01
4.2e-01
cases:8.43%
controls:5.41%
cases:6.87%
controls:3.48%
cases:1.11%
controls:0.40%
—
—
cases:2.00%
controls:0.20%
cases:5.10%
controls:4.02%
cases:19.17%
controls:13.51%
38
244
413
4266
31
157
420
4353
5
18
446
4492
—
9
9
442
4499
22
177
409
4229
69
511
291
3272
enoxaparin; parenteral
B01AB05 [21600976]
B01AB05 [21600976]
4.6e-01
6.6e-01
—
—
2.1e+00
9.0e-01
4.2e-01
cases:8.87%
controls:5.81%
cases:3.55%
controls:1.86%
—
—
—
—
cases:2.00%
controls:0.24%
cases:5.10%
controls:2.13%
cases:8.33%
controls:5.63%
40
262
411
4248
16
84
435
4426
—
—
9
11
442
4497
22
94
409
4312
30
213
330
3570
Obstetrics / Gynecology
16 [38004461]
16 [38004461]
2.8e-02
3.0e-01
3.4e-01
3.0e+00
6.9e-01
4.9e-01
4.3e-01
cases:13.97%
controls:13.64%
cases:7.76%
controls:5.88%
cases:1.55%
controls:1.11%
cases:2.22%
controls:0.11%
cases:2.66%
controls:1.35%
cases:7.89%
controls:4.99%
cases:21.39%
controls:15.01%
63
615
388
3895
35
265
416
4245
7
50
444
4460
10
5
441
4505
12
61
439
4447
34
220
397
4186
77
568
283
3215
Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
40982-1 [3038288]
40982-1 [3038288]
2.5e-01
1.2e+00
—
—
2.1e+00
1.1e+00
7.0e-01
cases:2.66%
controls:2.08%
cases:3.55%
controls:1.09%
—
—
—
—
cases:1.11%
controls:0.13%
cases:3.25%
controls:1.11%
cases:9.17%
controls:4.76%
12
94
439
4416
16
49
435
4461
—
—
5
6
446
4502
14
49
417
4357
33
180
327
3603
Normoblasts [#/volume] in Blood
715-3 [3021589]
715-3 [3021589]
-1.1e-01
6.3e-02
1.1e+00
—
1.2e+00
4.7e-01
7.4e-01
cases:9.98%
controls:11.04%
cases:9.53%
controls:9.00%
cases:6.87%
controls:2.48%
—
—
cases:6.43%
controls:2.06%
cases:15.55%
controls:10.30%
cases:38.33%
controls:22.84%
45
498
406
4012
43
406
408
4104
31
112
420
4398
—
29
93
422
4415
67
454
364
3952
138
864
222
2919
Hepatitis C virus Ab [Presence] in Serum
16128-1 [3017143]
16128-1 [3017143]
8.2e-01
8.5e-01
-1.0e+50
—
—
1.3e+00
9.1e-01
cases:5.99%
controls:2.73%
cases:3.77%
controls:1.64%
cases:0.00%
controls:0.13%
—
—
—
—
cases:3.94%
controls:1.16%
cases:10.28%
controls:4.41%
27
123
424
4387
17
74
434
4436
0
6
451
4504
—
—
17
51
414
4355
37
167
323
3616
Ferritin [Mass/volume] in Serum or Plasma
2276-4 [3001122]
2276-4 [3001122]
3.7e-01
4.3e-01
1.0e+00
—
1.7e+00
7.4e-01
4.9e-01
cases:14.19%
controls:10.22%
cases:9.53%
controls:6.43%
cases:2.22%
controls:0.82%
—
—
cases:4.21%
controls:0.78%
cases:14.15%
controls:7.29%
cases:34.72%
controls:24.66%
64
461
387
4049
43
290
408
4220
10
37
441
4473
—
19
35
432
4473
61
321
370
4085
125
933
235
2850
Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
21573-1 [3003031]
21573-1 [3003031]
9.9e-01
9.9e-01
—
—
—
1.3e+00
7.0e-01
cases:6.65%
controls:2.57%
cases:3.10%
controls:1.18%
—
—
—
—
—
—
cases:3.94%
controls:1.16%
cases:9.72%
controls:5.08%
30
116
421
4394
14
53
437
4457
—
—
—
17
51
414
4355
35
192
325
3591
Concussion
S06.0 [45582805]
S06.0 [45582805]
1.3e+00
1.6e+00
—
—
—
—
5.4e-01
cases:4.66%
controls:1.31%
cases:2.22%
controls:0.44%
—
—
—
—
—
—
—
—
cases:2.78%
controls:1.64%
21
59
430
4451
10
20
441
4490
—
—
—
—
10
62
350
3721
Urgent procedure
ZXD05 [2001311386]
ZXD05 [2001311386]
8.2e-01
9.7e-01
—
—
—
4.6e-01
1.1e+00
cases:10.20%
controls:4.77%
cases:3.77%
controls:1.46%
—
—
—
—
—
—
cases:1.39%
controls:0.89%
cases:7.22%
controls:2.43%
46
215
405
4295
17
66
434
4444
—
—
—
6
39
425
4367
26
92
334
3691
Counselling and guidance which enhance independent living
R2130 [2001310196]
R2130 [2001310196]
3.4e-02
—
—
—
—
1.8e+00
1.2e+00
cases:1.33%
controls:1.29%
—
—
—
—
—
—
—
—
cases:2.09%
controls:0.36%
cases:4.17%
controls:1.35%
6
58
445
4452
—
—
—
—
9
16
422
4390
15
51
345
3732
Retention of urine
R33 [45587507]
R33 [45587507]
1.3e+00
1.6e+00
—
—
—
—
3.4e-01
cases:3.55%
controls:1.00%
cases:2.00%
controls:0.40%
—
—
—
—
—
—
—
—
cases:2.22%
controls:1.59%
16
45
435
4465
9
18
442
4492
—
—
—
—
8
60
352
3723
Acute tubulo-interstitial nephritis
N10 [45543856]
N10 [45543856]
8.3e-01
1.9e+00
—
—
—
1.0e+00
1.0e+00
cases:3.55%
controls:1.57%
cases:2.22%
controls:0.33%
—
—
—
—
—
—
cases:1.86%
controls:0.66%
cases:6.94%
controls:2.67%
16
71
435
4439
10
15
441
4495
—
—
—
8
29
423
4377
25
101
335
3682
Thorax X-ray examination
GD1AA [2001303617]
GD1AA [2001303617]
5.5e-01
9.2e-01
1.4e+00
1.0e+50
5.8e-01
6.2e-01
4.5e-01
cases:18.63%
controls:11.71%
cases:10.64%
controls:4.52%
cases:2.22%
controls:0.53%
cases:2.00%
controls:0.00%
cases:1.11%
controls:0.62%
cases:6.96%
controls:3.88%
cases:17.78%
controls:12.11%
84
528
367
3982
48
204
403
4306
10
24
441
4486
9
0
442
4510
5
28
446
4480
30
171
401
4235
64
458
296
3325
zopiclone; oral
N05CF01 [21604654]
N05CF01 [21604654]
7.1e-01
7.1e-01
8.0e-01
—
5.6e-01
6.4e-01
8.4e-01
cases:15.30%
controls:8.16%
cases:9.76%
controls:5.03%
cases:2.44%
controls:1.11%
—
—
cases:2.00%
controls:1.15%
cases:8.58%
controls:4.70%
cases:15.00%
controls:7.08%
69
368
382
4142
44
227
407
4283
11
50
440
4460
—
9
52
442
4456
37
207
394
4199
54
268
306
3515
No disease
A97 [2002000230]
A97 [2002000230]
1.2e-02
5.4e-01
2.2e+00
—
—
7.4e-02
7.3e-01
cases:3.77%
controls:3.73%
cases:2.44%
controls:1.44%
cases:1.33%
controls:0.16%
—
—
—
—
cases:1.39%
controls:1.29%
cases:10.56%
controls:5.39%
17
168
434
4342
11
65
440
4445
6
7
445
4503
—
—
6
57
425
4349
38
204
322
3579
Acute suppurative otitis media
H66.0 [45572040]
H66.0 [45572040]
1.5e+00
—
—
—
—
—
1.3e+00
cases:2.44%
controls:0.53%
—
—
—
—
—
—
—
—
—
—
cases:3.06%
controls:0.82%
11
24
440
4486
—
—
—
—
—
11
31
349
3752
Schizophrenia, unspecified
F20.9 [45576533]
F20.9 [45576533]
1.4e+00
—
—
—
—
—
2.8e+00
cases:1.33%
controls:0.33%
—
—
—
—
—
—
—
—
—
—
cases:2.22%
controls:0.13%
6
15
445
4495
—
—
—
—
—
8
5
352
3778
Upper gastrointestinal surgery
106 [44777669]
106 [44777669]
4.9e-01
8.6e-01
4.5e-01
—
1.1e+00
7.1e-01
7.9e-01
cases:16.63%
controls:10.93%
cases:10.64%
controls:4.81%
cases:1.55%
controls:1.00%
—
—
cases:2.66%
controls:0.89%
cases:8.58%
controls:4.43%
cases:24.17%
controls:12.66%
75
493
376
4017
48
217
403
4293
7
45
444
4465
—
12
40
439
4468
37
195
394
4211
87
479
273
3304
Angioneurotic oedema
T78.3 [45551447]
T78.3 [45551447]
—
—
—
1.0e+50
1.0e+50
1.0e+50
2.8e+00
—
—
—
—
—
—
cases:6.21%
controls:0.00%
cases:2.22%
controls:0.00%
cases:3.94%
controls:0.00%
cases:3.06%
controls:0.19%
—
—
—
28
0
423
4510
10
0
441
4508
17
0
414
4406
11
7
349
3776
Psychological sympt/compl other
P29 [2002000823]
P29 [2002000823]
6.2e-01
1.2e+00
—
—
—
1.5e+00
1.3e+00
cases:2.00%
controls:1.09%
cases:1.33%
controls:0.42%
—
—
—
—
—
—
cases:2.09%
controls:0.45%
cases:6.11%
controls:1.80%
9
49
442
4461
6
19
445
4491
—
—
—
9
20
422
4386
22
68
338
3715
Specific gravity of Urine by Test strip
5811-5 [3000330]
5811-5 [3000330]
1.6e+00
1.2e+00
—
—
—
5.4e-01
7.4e-01
cases:5.10%
controls:1.11%
cases:3.10%
controls:0.93%
—
—
—
—
—
—
cases:1.86%
controls:1.09%
cases:6.39%
controls:3.15%
23
50
428
4460
14
42
437
4468
—
—
—
8
48
423
4358
23
119
337
3664
Ketones [Presence] in Urine by Test strip
2514-8 [3035350]
2514-8 [3035350]
3.9e-01
7.2e-01
8.6e-01
—
1.5e+00
4.5e-01
5.5e-01
cases:18.40%
controls:13.26%
cases:15.08%
controls:7.94%
cases:2.88%
controls:1.24%
—
—
cases:4.66%
controls:1.06%
cases:13.23%
controls:8.83%
cases:38.61%
controls:26.62%
83
598
368
3912
68
358
383
4152
13
56
438
4454
—
21
48
430
4460
57
389
374
4017
139
1007
221
2776
Glucose [Presence] in Urine by Test strip
25428-4 [3009261]
25428-4 [3009261]
3.8e-01
7.0e-01
8.2e-01
—
1.5e+00
4.9e-01
5.5e-01
cases:18.63%
controls:13.50%
cases:15.08%
controls:8.12%
cases:2.88%
controls:1.29%
—
—
cases:4.66%
controls:1.04%
cases:13.69%
controls:8.85%
cases:38.61%
controls:26.59%
84
609
367
3901
68
366
383
4144
13
58
438
4452
—
21
47
430
4461
59
390
372
4016
139
1006
221
2777
Nitrite [Presence] in Urine by Test strip
5802-4 [3021601]
5802-4 [3021601]
3.8e-01
7.0e-01
9.0e-01
—
1.5e+00
4.9e-01
5.1e-01
cases:17.96%
controls:13.02%
cases:14.86%
controls:7.96%
cases:2.88%
controls:1.20%
—
—
cases:4.43%
controls:1.00%
cases:13.46%
controls:8.69%
cases:37.50%
controls:26.43%
81
587
370
3923
67
359
384
4151
13
54
438
4456
—
20
45
431
4463
58
383
373
4023
135
1000
225
2783
Asthma, unspecified
J45.9 [45562456]
J45.9 [45562456]
7.1e-01
6.9e-01
1.7e+00
—
1.2e+00
1.0e+00
1.0e+00
cases:7.98%
controls:4.10%
cases:3.55%
controls:1.82%
cases:1.55%
controls:0.29%
—
—
cases:1.33%
controls:0.40%
cases:4.87%
controls:1.79%
cases:12.78%
controls:5.10%
36
185
415
4325
16
82
435
4428
7
13
444
4497
—
6
18
445
4490
21
79
410
4327
46
193
314
3590
Atrial fibrillation and flutter
I48 [45596206]
I48 [45596206]
3.3e-01
4.5e-01
1.3e+00
—
1.4e+00
6.7e-01
4.2e-01
cases:9.31%
controls:6.85%
cases:6.21%
controls:4.06%
cases:2.88%
controls:0.80%
—
—
cases:3.77%
controls:0.93%
cases:6.96%
controls:3.70%
cases:10.83%
controls:7.40%
42
309
409
4201
28
183
423
4327
13
36
438
4474
—
17
42
434
4466
30
163
401
4243
39
280
321
3503
Other and unspecified abdominal pain
R10.4 [45568113]
R10.4 [45568113]
5.7e-01
1.3e+00
1.6e+00
—
—
5.9e-01
8.4e-01
cases:11.09%
controls:6.59%
cases:7.10%
controls:2.04%
cases:1.11%
controls:0.22%
—
—
—
—
cases:3.94%
controls:2.22%
cases:16.39%
controls:7.80%
50
297
401
4213
32
92
419
4418
5
10
446
4500
—
—
17
98
414
4308
59
295
301
3488
Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
14685-2 [3009035]
14685-2 [3009035]
2.9e-01
5.3e-01
1.9e+00
—
—
6.2e-01
8.1e-01
cases:8.20%
controls:6.25%
cases:3.99%
controls:2.39%
cases:1.55%
controls:0.24%
—
—
—
—
cases:4.87%
controls:2.68%
cases:16.67%
controls:8.17%
37
282
414
4228
18
108
433
4402
7
11
444
4499
—
—
21
118
410
4288
60
309
300
3474
Fever, unspecified
R50.9 [45582716]
R50.9 [45582716]
7.7e-01
1.7e+00
—
—
—
1.0e+00
9.3e-01
cases:4.21%
controls:2.00%
cases:3.77%
controls:0.69%
—
—
—
—
—
—
cases:1.86%
controls:0.68%
cases:7.50%
controls:3.09%
19
90
432
4420
17
31
434
4479
—
—
—
8
30
423
4376
27
117
333
3666
Other and unspecified convulsions
R56.8 [45602033]
R56.8 [45602033]
1.3e+00
2.7e+00
—
—
—
—
1.2e+00
cases:2.00%
controls:0.58%
cases:1.55%
controls:0.11%
—
—
—
—
—
—
—
—
cases:2.22%
controls:0.66%
9
26
442
4484
7
5
444
4505
—
—
—
—
8
25
352
3758
Chronic viral hepatitis C
B18.2 [45590846]
B18.2 [45590846]
2.0e+00
—
—
—
—
—
2.6e+00
cases:1.11%
controls:0.16%
—
—
—
—
—
—
—
—
—
—
cases:2.50%
controls:0.19%
5
7
446
4503
—
—
—
—
—
9
7
351
3776
Addiction-induced dependence is currently independent but uses substitute intermittent medication
F11.22 [2000501716]
F11.22 [2000501716]
—
—
—
—
—
—
2.6e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.50%
controls:0.19%
—
—
—
—
—
—
9
7
351
3776
Implementation of physical therapy rehabilitation plan
SPAT1223 [2001700324]
SPAT1223 [2001700324]
7.8e-01
9.9e-01
—
—
8.8e-01
6.5e-01
8.5e-01
cases:12.86%
controls:6.34%
cases:6.65%
controls:2.57%
—
—
—
—
cases:1.33%
controls:0.55%
cases:4.87%
controls:2.61%
cases:12.22%
controls:5.63%
58
286
393
4224
30
116
421
4394
—
—
6
25
445
4483
21
115
410
4291
44
213
316
3570
Drug abuse
P19 [2002000815]
P19 [2002000815]
—
—
—
—
—
—
2.6e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.78%
controls:0.21%
—
—
—
—
—
—
10
8
350
3775
Abdominal CT examination
JN3AD [2001305554]
JN3AD [2001305554]
9.0e-01
1.5e+00
—
—
—
8.8e-01
1.1e+00
cases:2.22%
controls:0.91%
cases:2.22%
controls:0.49%
—
—
—
—
—
—
cases:1.62%
controls:0.68%
cases:8.89%
controls:3.25%
10
41
441
4469
10
22
441
4488
—
—
—
7
30
424
4376
32
123
328
3660
Extensive structural and functional ultrasound examination of heart
FM1EE [2001303307]
FM1EE [2001303307]
8.4e-01
9.5e-01
1.5e+00
—
—
7.4e-01
7.7e-01
cases:10.20%
controls:4.66%
cases:5.99%
controls:2.39%
cases:1.11%
controls:0.24%
—
—
—
—
cases:4.64%
controls:2.27%
cases:12.22%
controls:6.05%
46
210
405
4300
27
108
424
4402
5
11
446
4499
—
—
20
100
411
4306
44
229
316
3554
Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
72720-6 [43055554]
72720-6 [43055554]
9.9e-01
1.5e+00
—
—
—
1.2e+00
1.0e+00
cases:3.33%
controls:1.26%
cases:3.33%
controls:0.75%
—
—
—
—
—
—
cases:2.78%
controls:0.89%
cases:5.83%
controls:2.14%
15
57
436
4453
15
34
436
4476
—
—
—
12
39
419
4367
21
81
339
3702
Osteomyelitis, unspecified
M86.9 [45577456]
M86.9 [45577456]
—
—
—
—
—
—
2.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.67%
controls:0.13%
—
—
—
—
—
—
6
5
354
3778
Fitting of intermediary dental prosthesis structures, 1 to 3 units
SPA60 [2001310485]
SPA60 [2001310485]
—
—
—
—
—
—
2.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.67%
controls:0.13%
—
—
—
—
—
—
6
5
354
3778
Amputation of toe
NHQ40 [2001308365]
NHQ40 [2001308365]
—
—
—
—
1.0e+50
—
2.5e+00
—
—
—
—
—
—
—
—
cases:1.33%
controls:0.00%
—
—
cases:1.94%
controls:0.16%
—
—
—
—
6
0
445
4508
—
7
6
353
3777
Acetaminophen [Moles/volume] in Serum or Plasma
14581-3 [3020485]
14581-3 [3020485]
—
—
—
—
—
—
2.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.94%
controls:0.16%
—
—
—
—
—
—
7
6
353
3777
Sequelae with surgical and medical care as external cause
Y88 [45755974]
Y88 [45755974]
—
—
—
—
—
—
2.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.94%
controls:0.16%
—
—
—
—
—
—
7
6
353
3777
Enterocolitis due to Clostridium difficile
A04.7 [45552153]
A04.7 [45552153]
2.1e+00
—
—
—
—
—
2.5e+00
cases:1.11%
controls:0.13%
—
—
—
—
—
—
—
—
—
—
cases:1.94%
controls:0.16%
5
6
446
4504
—
—
—
—
—
7
6
353
3777
hydroxyzine; oral, parenteral
N05BB01 [21604590]
N05BB01 [21604590]
5.5e-01
1.3e+00
—
—
—
1.2e+00
6.9e-01
cases:4.43%
controls:2.62%
cases:3.33%
controls:0.89%
—
—
—
—
—
—
cases:3.02%
controls:0.95%
cases:5.56%
controls:2.85%
20
118
431
4392
15
40
436
4470
—
—
—
13
42
418
4364
20
108
340
3675
Telephone prescription or other care instructions
WZB00 [2001310884]
WZB00 [2001310884]
5.9e-01
9.9e-01
1.6e+00
—
—
8.5e-01
9.3e-01
cases:11.97%
controls:6.98%
cases:4.66%
controls:1.77%
cases:1.11%
controls:0.22%
—
—
—
—
cases:3.94%
controls:1.72%
cases:12.22%
controls:5.21%
54
315
397
4195
21
80
430
4430
5
10
446
4500
—
—
17
76
414
4330
44
197
316
3586
macrogol; oral
A06AD15 [21600575]
A06AD15 [21600575]
7.4e-01
1.4e+00
—
—
—
9.2e-01
1.1e+00
cases:3.55%
controls:1.73%
cases:2.66%
controls:0.67%
—
—
—
—
—
—
cases:2.09%
controls:0.84%
cases:8.89%
controls:3.12%
16
78
435
4432
12
30
439
4480
—
—
—
9
37
422
4369
32
118
328
3665
LabWAS
↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
99
329
3.57
24.98
13.6
6.7
9.93
9.41
mmol/l
0.26
92
310
290
1785
2.75
23.25
19.5
13.0
1.22
1.22
inr
0.03
259
1495
223
1269
2.50
20.08
5.4
2.5
51.06
63.27
u/l
2.37
217
1186
64
186
3.84
19.47
7.3
3.3
25.55
25.00
mmol/l
0.60
59
179
100
386
3.04
19.41
10.9
3.3
1.86
1.84
mmol/l
0.02
88
326
294
1931
2.50
18.88
16.5
6.8
1.21
1.21
mmol/l
0.18
267
1687
31
51
6.45
18.36
3.0
2.6
106.42
105.61
mmol/l
0.39
31
51
31
51
6.45
18.36
3.0
2.6
4.06
3.98
mmol/l
0.49
31
51
140
669
2.58
17.93
5.2
2.4
12.29
13.58
umol/l
0.99
131
621
132
619
2.60
17.53
5.3
2.4
2.29
2.34
g/l
0.37
122
573
123
565
2.62
16.97
5.4
2.5
22.01
23.64
%
0.47
113
530
305
2098
2.40
16.73
9.6
6.6
9.76
11.44
umol/l
2.25
297
1997
115
520
2.63
16.32
14.2
5.7
1.13
1.04
mmol/l
2.21
109
476
257
1666
2.26
15.91
9.3
4.8
34.57
35.96
g/l
3.30
251
1578
323
2309
2.41
15.75
10.1
4.8
7.00
6.59
mmol/l
2.59
318
2176
75
275
3.07
15.73
2.4
1.6
—
—
—
0
0
132
648
2.47
15.69
5.8
3.2
0.80
0.82
mmol/l
1.01
127
616
28
51
5.79
14.96
3.2
2.6
1.21
1.19
mmol/l
0.75
28
51
25
20
13.16
14.55
3.7
2.4
296.85
85.67
umol/l
—
13
9
114
544
2.47
14.26
9.3
6.7
103.72
104.28
mmol/l
0.49
114
544
273
1865
2.18
14.18
4.2
2.7
—
—
estimate
—
0
0
128
658
2.32
13.46
2.9
1.9
—
—
—
0
0
64
234
3.02
13.42
8.0
6.5
24.45
24.50
mmol/l
0.04
57
223
198
1215
2.12
13.38
3.0
2.1
204.71
199.35
u/l
0.05
193
1155
147
803
2.23
13.35
2.0
1.7
451.36
16786657.54
pmol/l
0.50
137
697
61
219
3.06
13.20
4.8
2.7
2.15
1.92
mmol/l
0.15
44
156
39
105
3.97
13.11
3.1
1.6
—
—
—
0
0
219
1429
2.04
12.23
4.4
3.3
31.41
33.33
u/l
0.23
209
1363
119
619
2.25
12.01
1.9
1.6
1215.87
1212.47
nmol/l
0.01
100
477
102
498
2.35
11.94
2.4
1.8
—
—
—
0
0
373
2989
2.43
11.80
14.0
8.2
79.03
79.01
u/l
0.00
365
2833
92
443
2.35
11.05
4.2
4.5
212.51
242.75
u/l
2.73
87
419
192
1233
1.97
10.87
5.3
3.1
0.00
0.01
estimate
0.80
83
380
224
1516
1.95
10.86
6.5
3.6
32.74
35.14
ng/l
0.17
167
1019
201
1321
1.94
10.55
5.1
3.3
7.06
7.96
mmol/l
1.78
181
1126
42
138
3.25
10.50
2.1
1.8
251.56
250.68
ug/l
0.00
42
133
88
430
2.30
10.17
7.9
7.8
1.81
0.88
mmol/l
1.23
68
358
79
369
2.38
10.12
2.6
2.5
0.21
0.22
g/l
0.29
74
346
302
2299
1.95
9.90
14.9
9.8
4.40
4.13
e9/l
1.25
286
2011
88
437
2.26
9.77
8.0
7.7
5.32
5.09
kpa
1.02
82
419
88
437
2.26
9.77
8.0
7.7
12.42
12.07
kpa
0.20
81
422
77
364
2.35
9.58
8.1
8.5
117.44
121.57
g/l
0.99
72
355
65
288
2.47
9.32
7.6
3.9
142.01
84.48
ng/l
1.83
53
255
243
1751
1.84
9.16
3.5
2.5
69.46
74.95
nmol/l
2.27
222
1593
92
478
2.16
9.10
2.5
1.9
—
—
—
0
0
163
1039
1.89
9.07
3.8
2.1
3.03
2.94
mg/l
0.20
148
908
237
1699
1.83
9.04
2.4
2.1
95.15
95.87
pmol/l
0.08
145
909
174
1142
1.85
8.77
2.0
1.6
18.72
20.03
nmol/l
0.55
153
975
280
2138
1.82
8.43
6.0
3.7
0.00
0.00
estimate
-0.00
97
466
90
477
2.11
8.42
3.1
2.7
9.19
7.80
umol/l
0.20
75
419
237
1726
1.79
8.34
14.7
5.9
1.21
1.21
mmol/l
0.15
225
1595
181
1220
1.81
8.25
5.2
4.2
17.21
10.84
mg/mmol
0.45
121
777
50
209
2.57
8.08
6.0
8.9
16.27
15.82
%
0.52
45
199
33
110
3.16
8.06
1.7
1.2
—
—
—
0
0
73
362
2.21
8.06
7.5
3.2
—
—
—
0
0
280
2156
1.79
8.01
6.0
3.8
0.00
0.02
estimate
0.79
91
439
36
128
2.97
7.89
1.7
1.3
—
—
—
0
0
318
2549
1.84
7.89
7.8
4.4
14451.29
435.56
e6/l
—
7
43
51
219
2.50
7.80
8.7
2.3
0.62
0.63
%
0.03
51
219
47
194
2.59
7.79
2.4
1.5
—
—
—
0
0
188
1299
1.77
7.77
5.5
3.1
45.20
118.17
e6/l
0.77
167
993
31
102
3.19
7.74
2.2
1.6
—
—
—
0
0
168
1125
1.79
7.72
3.8
3.2
3447.10
1177.32
ng/l
1.60
152
953
275
2121
1.76
7.67
6.0
3.7
0.00
0.00
estimate
-0.00
95
461
96
550
1.95
7.17
2.0
1.9
1.57
1.46
%
0.80
73
494
31
107
3.04
7.16
2.5
1.6
—
—
—
0
0
222
1639
1.70
7.02
6.1
3.6
0.00
0.02
estimate
1.15
84
386
258
1983
1.70
7.02
5.2
3.0
126.55
117.81
ug/l
0.31
242
1881
138
893
1.79
7.00
4.4
2.5
5.66
6.42
e6/l
0.26
132
814
26
84
3.22
6.70
13.5
6.3
112.17
173.75
iu/ml
—
6
8
23
70
3.41
6.50
6.1
2.9
5.17
5.05
kpa
0.50
23
70
348
2945
1.80
6.31
6.4
4.2
15.64
11.11
mm/h
4.88
330
2754
151
1032
1.70
6.19
4.0
2.7
333.28
344.55
umol/l
0.60
139
921
20
58
3.56
6.08
2.1
1.3
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
26
90
3.00
5.99
3.9
2.5
0.40
0.37
iu/ml
0.10
16
49
10
9
11.33
5.82
1.4
2.0
13.82
14.34
umol/l
—
10
9
19
57
3.44
5.50
2.1
1.3
—
—
—
0
0
158
1122
1.63
5.46
4.5
3.0
0.30
0.34
e6/l
0.21
138
814
164
1176
1.62
5.45
6.5
3.8
0.00
0.01
estimate
0.96
88
440
8
5
16.24
5.43
19.9
6.6
4.97
5.24
mmol/l
—
8
5
46
222
2.19
5.41
2.2
1.7
—
—
—
0
0
113
740
1.70
5.32
5.2
3.9
104.02
357.54
ng/l
1.78
81
549
20
64
3.22
5.25
2.6
1.7
—
—
—
0
0
38
174
2.29
5.07
2.1
2.2
1.80
1.46
g/l
1.09
32
153
19
61
3.21
4.97
5.2
6.3
443.26
345.55
umol/l
0.50
19
55
18
56
3.31
4.94
2.2
1.3
—
—
—
0
0
18
56
3.31
4.94
2.2
1.3
—
—
—
0
0
21
72
3.01
4.94
7.0
2.9
18.22
9.54
pmol/l
0.86
21
72
31
132
2.45
4.86
1.5
1.6
0.11
0.06
iu/ml
—
6
24
18
57
3.25
4.81
2.2
1.3
—
—
—
0
0
134
939
1.61
4.79
2.1
1.7
0.99
1.20
mg/l
0.73
116
724
16
47
3.49
4.79
2.1
1.6
—
—
—
0
0
29
122
2.47
4.66
2.4
3.1
—
—
—
0
0
31
136
2.37
4.56
2.8
2.1
—
—
—
0
0
421
3893
2.22
4.48
37.8
15.1
22.67
22.67
mg/l
0.00
385
3192
324
2792
1.57
4.40
6.2
3.3
58.59
46.07
u/l
1.13
313
2659
404
3688
1.92
4.37
29.3
14.7
83.32
84.18
ml/min/173m2
0.27
394
3419
39
196
2.08
4.17
3.6
2.2
2040.28
6183.79
u/l
0.82
17
79
17
58
3.01
4.05
2.3
1.3
—
—
—
0
0
15
48
3.20
3.96
1.7
1.5
—
—
—
0
0
18
65
2.84
3.90
1.6
1.6
—
—
—
0
0
394
3597
1.75
3.88
5.0
4.1
1.36
1.28
mmol/l
1.18
369
3354
23
95
2.50
3.87
1.7
1.5
—
—
—
0
0
38
197
2.01
3.75
1.5
1.9
2.14
6.93
iu/ml
—
10
47
28
129
2.25
3.72
2.5
1.9
—
—
—
0
0
16
56
2.93
3.66
2.8
1.8
1.44
1.69
mmol/l
0.95
16
56
43
236
1.91
3.62
12.7
8.1
25.50
24.68
mmol/l
0.44
43
236
22
92
2.46
3.62
1.7
1.2
198.67
275.02
u/ml
0.70
15
46
346
3080
1.53
3.56
5.4
4.4
14.56
14.65
pmol/l
0.33
327
2818
14
47
3.04
3.44
1.4
1.3
—
—
—
0
0
22
95
2.38
3.39
1.2
1.8
—
—
—
0
0
429
4054
2.19
3.34
19.6
11.7
26.12
26.82
u/l
0.36
424
3955
17
65
2.68
3.34
1.2
1.3
—
—
—
0
0
6
7
8.67
3.27
1.7
1.3
—
—
—
0
0
24
111
2.23
3.18
4.4
2.8
4.05
2.36
ratio
0.24
16
62
405
3780
1.70
2.97
5.7
4.8
1.39
1.45
mmol/l
2.00
386
3542
19
82
2.38
2.95
1.6
1.6
—
—
—
0
0
19
82
2.38
2.95
1.7
1.5
—
—
—
0
0
388
3586
1.59
2.93
9.5
6.1
41.72
38.99
mmol/mol
4.85
374
3390
11
32
3.50
2.92
1.6
2.6
—
—
—
0
0
20
89
2.31
2.91
2.3
1.3
—
—
—
0
0
90
640
1.51
2.90
4.7
2.9
6.53
2.06
e6/l
0.76
64
311
15
58
2.64
2.90
1.1
1.1
—
—
—
0
0
439
4213
2.58
2.84
50.7
23.0
4.35
4.52
e12/l
8.08
434
4144
439
4213
2.58
2.84
51.2
23.4
39.17
40.58
%
6.58
434
4172
22
104
2.17
2.79
1.4
1.2
—
1.00
—
0
7
20
91
2.25
2.78
2.1
2.5
393.60
66.77
ug/min
0.52
15
51
27
139
2.00
2.76
1.3
1.2
—
1.58
—
0
5
26
132
2.03
2.76
1.4
1.3
3.10
6.09
u/ml
—
5
23
5
6
8.41
2.75
1.2
1.0
96.20
102.50
%
—
5
6
5
6
8.41
2.75
1.0
1.2
—
—
—
0
0
5
6
8.41
2.75
1.0
1.2
—
—
—
0
0
7
14
5.06
2.74
1.1
1.1
—
—
—
0
0
37
214
1.79
2.69
1.9
1.6
0.31
0.32
mg/l
0.03
21
100
9
24
3.80
2.68
2.0
1.4
—
—
—
0
0
9
24
3.80
2.68
2.0
1.4
—
—
—
0
0
405
3798
1.65
2.68
5.8
4.9
4.40
4.64
mmol/l
5.00
385
3572
28
148
1.95
2.67
3.6
1.9
4.11
4.34
g/l
0.54
28
137
28
148
1.95
2.67
3.6
1.9
3.71
3.88
g/l
0.12
28
137
28
148
1.95
2.67
3.6
1.9
7.50
7.32
g/l
0.20
28
137
11
35
3.20
2.66
1.1
1.1
—
—
—
0
0
7
15
4.72
2.60
2.9
4.9
—
—
—
0
0
388
3609
1.54
2.59
6.5
5.4
1.81
1.89
mu/l
0.89
368
3360
9
25
3.65
2.58
1.3
1.8
16.74
11.80
umol/l
—
9
25
11
36
3.11
2.58
1.1
1.1
—
—
—
0
0
8
20
4.05
2.58
2.0
1.3
—
—
—
0
0
8
20
4.05
2.58
2.0
1.3
—
—
—
0
0
12
42
2.91
2.56
2.8
1.8
91.78
91.56
%
0.06
12
42
409
3853
1.66
2.55
6.3
5.5
2.49
2.73
mmol/l
6.50
390
3621
133
1042
1.39
2.54
1.4
1.3
1.91
1.99
u/ml
0.02
49
306
111
844
1.42
2.52
1.8
1.6
—
—
—
0
0
23
116
2.04
2.50
3.2
2.1
3.40
3.72
g/l
0.41
23
111
7
16
4.43
2.48
1.1
1.2
—
—
—
0
0
18
83
2.22
2.44
2.5
1.3
134.20
159.39
au/ml
—
5
24
59
398
1.56
2.42
2.9
4.5
3.85
36.24
ug/l
0.96
46
326
15
64
2.39
2.41
1.1
1.6
—
—
—
0
0
9
27
3.38
2.40
1.2
1.7
—
—
—
0
0
160
1302
1.35
2.40
4.1
3.5
2.36
2.35
mmol/l
0.42
145
1189
5
8
6.30
2.37
1.0
1.4
—
—
—
0
0
7
17
4.17
2.37
1.6
3.8
382.43
770.12
u/ml
—
7
17
11
39
2.87
2.36
1.0
1.1
—
—
—
0
0
23
120
1.97
2.30
1.4
1.3
341.75
311.83
ug/g
—
8
64
8
23
3.52
2.28
1.1
1.0
—
—
—
0
0
8
23
3.52
2.28
1.6
2.3
—
—
—
0
0
17
79
2.20
2.27
1.5
1.6
—
—
—
0
0
11
41
2.72
2.22
1.0
1.1
—
—
—
0
0
19
95
2.04
2.14
1.1
1.1
3.35
1.84
u/ml
0.31
13
50
8
25
3.24
2.10
1.3
1.6
—
—
—
0
0
11
43
2.60
2.09
3.6
3.6
4.74
3.46
nmol/l
0.21
11
43
5
10
5.04
2.07
1.6
1.1
—
—
—
0
0
6
15
4.04
2.04
2.3
2.1
—
—
—
0
0
11
44
2.54
2.02
3.3
1.7
—
—
—
0
0
10
38
2.67
2.01
3.4
1.8
—
—
—
0
0
290
2616
1.30
1.95
4.2
3.3
—
—
—
0
0
118
943
1.34
1.95
6.6
3.7
1.02
1.02
kg/l
0.01
99
634
21
113
1.90
1.95
1.2
1.2
—
—
—
0
0
79
592
1.41
1.94
3.0
2.2
—
—
—
0
0
119
957
1.33
1.88
4.1
2.3
—
—
—
0
0
23
130
1.81
1.85
4.2
1.9
10.65
10.38
g/l
0.06
23
118
6
17
3.56
1.84
1.0
1.2
—
—
—
0
0
15
73
2.09
1.82
1.4
1.4
—
—
—
0
0
15
73
2.09
1.82
1.4
1.4
—
—
—
0
0
25
147
1.74
1.78
1.3
1.5
—
—
—
0
0
5
13
3.88
1.72
1.0
2.5
—
—
—
0
0
6
19
3.19
1.66
1.2
1.0
1507.83
1318.00
miu/ml
—
6
19
29
184
1.62
1.58
3.1
2.2
41.40
41.10
u/l
0.03
24
169
53
384
1.43
1.58
3.5
2.4
37.00
38.12
u/l
0.08
44
316
12
57
2.14
1.56
2.0
1.2
0.48
0.54
nmol/l
0.18
12
51
12
57
2.14
1.56
1.8
1.4
—
—
—
0
0
100
805
1.31
1.56
1.3
1.3
28.76
30.89
iu/ml
0.08
32
248
87
687
1.33
1.55
3.8
2.8
0.80
0.94
e6/l
0.32
62
360
5
15
3.36
1.52
2.8
4.0
12.08
10.41
kpa
—
5
15
5
15
3.36
1.52
2.8
4.0
5.49
4.68
kpa
—
5
15
44
310
1.46
1.52
4.0
2.6
51.81
66.59
ml/min/173m2
1.66
26
135
9
37
2.46
1.48
1.0
1.1
—
—
—
0
0
9
37
2.46
1.48
1.0
1.3
78.56
43.46
u/l
—
9
32
24
148
1.66
1.47
1.3
1.2
9.66
10.15
u/l
0.07
19
121
6
22
2.75
1.44
1.0
1.1
60.00
98.27
u/l
—
6
22
6
22
2.75
1.44
1.0
1.1
19.17
31.17
u/l
—
6
22
8
162
0.48
1.38
1.0
1.1
1.62
1.56
g/l
—
8
162
6
23
2.63
1.37
2.2
3.3
1.17
1.30
%
—
6
23
17
97
1.78
1.37
1.5
1.3
530.45
132.96
e6/l
0.72
11
73
5
17
2.96
1.36
1.0
1.4
—
—
—
0
0
91
738
1.29
1.35
1.3
1.3
11.96
9.73
u/ml
0.09
37
279
23
353
0.63
1.34
1.7
1.7
3.58
3.50
mmol/l
0.08
18
254
6
131
0.45
1.30
1.8
1.5
41.78
60.30
ug/l
—
6
115
387
3698
1.33
1.30
6.2
4.8
6.28
5.89
mmol/l
4.12
374
3424
5
117
0.42
1.26
2.0
1.5
—
—
—
0
0
16
93
1.75
1.22
2.1
1.4
—
—
—
0
0
9
168
0.53
1.21
1.3
1.1
0.79
0.92
g/l
—
9
168
40
291
1.41
1.20
2.1
2.3
5.85
6.63
ug/l
0.13
34
264
23
149
1.57
1.19
1.7
1.6
37.97
7.76
u/ml
—
6
31
79
640
1.28
1.18
3.3
2.4
—
—
—
0
0
16
95
1.71
1.15
1.7
1.3
102.78
9.68
e6/l
—
9
68
5
21
2.40
1.09
1.2
1.6
—
—
—
0
0
5
21
2.40
1.09
1.0
1.2
181.22
206.13
iu/ml
—
5
21
7
32
2.21
1.08
1.3
1.2
96.43
99.12
pmol/l
—
7
32
7
33
2.14
1.06
1.6
1.5
—
—
—
0
0
5
22
2.29
1.03
1.2
1.6
—
—
—
0
0
47
363
1.33
1.01
2.7
2.2
—
—
—
0
0
7
35
2.02
1.00
4.1
1.7
—
—
—
0
0
7
35
2.02
1.00
4.1
1.7
—
—
—
0
0
7
35
2.02
1.00
4.1
1.7
—
—
—
0
0
21
140
1.52
0.99
3.0
2.0
2.91
3.02
g/l
0.22
21
129
31
225
1.41
0.97
1.0
1.0
—
—
—
0
0
8
138
0.57
0.84
1.4
1.4
—
—
—
0
0
24
172
1.42
0.82
1.3
1.4
56.79
253.60
miu/ml
—
7
83
12
73
1.66
0.82
1.4
1.2
4.20
4.04
u/ml
—
5
28
31
235
1.34
0.78
10.8
9.5
24.90
24.33
mmol/l
0.27
31
230
17
115
1.50
0.78
1.5
1.3
—
—
—
0
0
9
53
1.71
0.76
1.4
1.3
—
—
—
0
0
86
743
1.19
0.75
2.9
2.8
2.46
2.44
mmol/l
0.74
80
663
5
24
2.10
0.74
3.0
3.2
0.40
0.83
index
—
5
24
17
117
1.47
0.73
1.3
1.1
—
—
—
0
0
17
117
1.47
0.73
1.3
1.1
—
—
—
0
0
5
27
1.86
0.68
1.6
3.2
387.20
1023.07
mg
—
5
27
138
1251
1.15
0.66
5.3
5.2
2.07
2.38
ug/l
0.32
120
1129
5
28
1.79
0.66
2.0
1.2
—
—
—
0
0
5
28
1.79
0.66
1.0
1.0
—
1.14
—
0
15
39
315
1.26
0.65
2.8
2.1
—
—
—
0
0
11
71
1.56
0.62
1.2
1.1
—
—
—
0
0
10
152
0.65
0.62
2.4
1.4
—
—
—
0
0
28
218
1.30
0.62
1.3
1.3
12.32
22.58
iu/l
2.78
23
183
5
30
1.67
0.61
1.6
1.0
—
—
—
0
0
17
123
1.40
0.58
1.9
2.0
2.32
4.38
iu/l
—
8
52
6
37
1.63
0.55
2.7
1.7
—
—
—
0
0
6
38
1.59
0.54
1.3
1.4
—
—
—
0
0
44
371
1.21
0.52
1.8
2.3
10.25
13.46
nmol/l
1.70
38
343
6
40
1.51
0.51
1.5
1.2
—
—
—
0
0
6
40
1.51
0.51
1.2
1.0
—
—
—
0
0
9
64
1.41
0.51
1.2
1.1
123.44
118.25
%
—
9
59
6
41
1.47
0.50
5.3
1.6
—
—
—
0
0
20
154
1.31
0.49
1.6
1.8
—
—
—
0
0
53
458
1.18
0.49
4.7
4.6
32.95
31.85
%
0.29
39
304
7
48
1.47
0.47
1.3
1.1
—
—
—
0
0
7
51
1.38
0.44
1.4
1.2
—
—
—
0
0
48
417
1.17
0.43
11.3
6.8
—
—
—
0
0
8
58
1.39
0.41
1.6
1.3
1.72
2.93
ug/l
—
8
52
0
15
0.00
0.41
0.0
1.2
—
8.73
—
0
15
20
159
1.27
0.41
1.9
1.3
—
—
—
0
0
5
37
1.36
0.37
2.0
1.3
—
—
—
0
0
6
42
1.43
0.35
1.5
1.2
—
—
—
0
0
6
42
1.43
0.35
1.5
1.2
—
—
—
0
0
6
46
1.31
0.33
1.5
1.2
—
—
—
0
0
156
1642
0.92
0.32
2.0
1.9
1.52
1.38
mmol/l
1.10
132
1411
26
222
1.18
0.30
1.2
1.3
—
—
—
0
0
5
39
1.29
0.23
2.0
1.5
—
—
—
0
0
7
91
0.77
0.22
1.7
1.5
110.46
54.44
ug/l
—
7
91
5
41
1.22
0.22
1.2
1.2
—
—
—
0
0
13
107
1.22
0.22
4.0
2.1
0.00
0.00
g/l
-0.00
13
102
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
8
101
0.79
0.21
2.1
1.7
—
—
—
0
0
15
126
1.20
0.21
1.5
1.5
—
—
—
0
0
9
115
0.78
0.20
1.2
1.6
—
—
—
0
0
6
49
1.23
0.20
2.0
1.9
13.33
13.40
%
—
6
49
6
52
1.16
0.19
1.3
1.1
101.17
98.40
%
—
6
47
6
52
1.16
0.19
1.3
1.2
—
—
—
0
0
7
59
1.19
0.18
1.9
1.6
—
—
—
0
0
11
92
1.20
0.16
1.4
1.3
—
—
—
0
0
71
748
0.94
0.16
3.3
3.1
0.77
0.76
ug/l
0.05
41
455
96
992
0.96
0.11
3.9
4.5
23.12
21.99
%
0.22
37
465
15
166
0.90
0.10
1.9
1.9
8.71
3.98
mg/l
—
10
131
5
46
1.09
0.09
2.6
3.3
—
—
—
0
0
11
98
1.13
0.07
2.4
1.2
—
—
—
0
0
65
638
1.02
0.03
1.7
1.5
—
—
—
0
0
32
310
1.03
0.03
1.4
1.3
101.50
151.58
u/ml
0.69
14
128
30
309
0.97
0.02
1.5
1.4
—
—
—
0
0
13
126
1.03
0.00
3.5
2.0
175.85
183.20
%
0.16
13
121
20
196
1.02
0.00
4.4
2.8
42.97
47.64
u/ml
0.05
20
187
0
6
0.00
-0.00
0.0
1.5
—
—
—
0
0
0
5
0.00
-0.00
0.0
4.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
5
54
0.93
-0.00
1.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.8
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: VWXY20_LIFESTYLE__CONDI – Lifestyle-related condition
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).